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AVANT PROPOS 
 
Le format de présentation de cette Thèse correspond à une 
recommandation de la spécialité Maladies Infectieuses et Microbiologie, 
à l’intérieur du Master des Sciences de la Vie et de la Santé qui dépend de 
l’Ecole Doctorale des Sciences de la Vie de Marseille. 
Le candidat est amené à respecter des règles qui lui sont imposées et 
qui comportent un format de thèse utilisé dans le Nord de l’Europe et qui 
permet un meilleur rangement que les thèses traditionnelles. Par ailleurs, 
la partie introduction et bibliographie est remplacée par une revue 
envoyée dans un journal afin de permettre une évaluation extérieure de la 
qualité de la revue et de permettre à l’Etudiant de commencer le plus tôt 
possible une bibliographie exhaustive sur le domaine de cette thèse. Par 
ailleurs, la thèse est présentée sur articles publiés, acceptés ou soumis, 
associés d’un bref commentaire donnant le sens général du travail. Cette 
forme de présentation a paru plus en adéquation avec les exigences de la 
compétition internationale et permet de se concentrer sur des travaux qui 
bénéficieront d’une diffusion internationale.  
  
                                        Professeur Didier RAOULT 
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RESUME 
 
Les rickettsies sont  de petites bactéries à Gram-négatif associées à 
différentes espèces d'arthropodes. Leur nature intracellulaire stricte a 
longtemps été un obstacle à la compréhension des mécanismes 
moléculaires responsables de leur pathogénicité qui restent mal connus. 
L’adhésion bactérienne, qui est une étape clef de l’invasion des tissus de 
l’hôte, met en jeu les protéines rOmpA et rOmpB (rickettsial outer 
membrane proteins),  identifiées depuis longtemps comme des antigènes 
de surface majeurs des rickettsies. L’objectif de cette thèse a été de 
caractériser une autre adhésine potentielle de Rickettsia prowazekii 
récemment identifiée, soit Adr2. La stratégie mise en œuvre a été basée 
sur la production  d’anticorps monoclonaux spécifiques de cette protéine, 
dont une forme recombinante a été exprimée. Cet outil a permis, non 
seulement de localiser Adr2 à la surface des rickettsies, mais aussi 
d’apporter la preuve de son rôle dans le phénomène invasif puisque les 
anticorps anti-Adr2 diminuent significativement la cytotoxicité des 
rickettsies sur les cellules épithéliales.   
Un autre aspect de la pathogénicité que nous avons abordé concerne 
la mobilité des rickettsies du groupe boutonneux, fonction attribuée à la 
protéine RickA lorsque ce travail a été initié. La résolution des images 
obtenues par  immunofluorescence, ou par microscopie électronique après 
marquage immunogold, montrent que l’expression de RickA est non-
polarisée et  répartie sur la surface entière de Rickettsia conorii. 
   Enfin, plusieurs protéines recombinantes ont été utilisées dans des 
tests de screening sérologiques avec des sérums de patients infectés par 
diverses rickettsies, avec des résultats encourageants. 
L’ensemble de ces résultats contribue à une meilleure connaissance 
de la pathogénicité des bactéries du genre  Rickettsia.  
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ABSTRACT 
 
Rickettsiae are characterized by their strictly intracellular location, as 
Gram-negative bacteria growing only within the eukaryotic host cell 
cytoplasm. Accordingly, the molecular mechanisms responsible for 
invasive mechanisms are largely unknown. Adhesion is a key step for 
bacterial invasion of host tissues and involves the rickettsial outer 
membrane proteins rOmpA and rOmpB, known for a long time as major 
rickettsial cell surface antigens. The aim of this thesis was to gain a better 
understanding of another newly identified rickettsial adhesin from 
Rickettsia prowazekii, called Adr2. This task was achieved through the 
production of a monoclonal antibody (mAb) specific for the recombinant 
protein and that allowed localization of Adr2 at the bacterial cell surface. 
The inhibition of rickettsiae-induced cytotoxicity with this mAb 
confirmed the role of Adr2 in the invasion process.  
Considering the putative role of the actin-based motility in the 
pathogenesis of the spotted fever group rickettsiae (SFG), we then 
focused our second part of work on the localization of RickA, a protein 
specific for the SFG rickettsiae and thought to be responsible for bacterial 
motility. Immunofluorescence assay combined with a immunogold 
electron microscopy yielded good-resolution images and showed a non-
polarized expression of RickA that was found onto the entire bacterial 
surface of Rickettsia conorii. 
   Finally, twenty recombinant proteins targets were screened with 
sera of patients infected with various rickettsiae. We thus evidenced 
several putaive markers allowing to discriminate infection caused either 
by Rickettsia typhi or by Rickettsia conorii. 
On the overall, we believe that our results improve the knowledge 
about the pathogenicity of bacteria from the Rickettsia genus.  
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I. GENERALITIES 
 
The genus Rickettsia includes bacterial obligate intracellular parasites 
associated with arthropods (tick, mite, flea, and lice) and that primarily 
target the microvascular endothelium. In the last two decades, new 
rickettsial pathogens have been associated with human illness around the 
world. Clinically, the common denominator in all rickettsioses is the 
development of increased microvascular permeability, leading to cerebral 
and non-cardiogenic pulmonary edema (Olano, 2005). Based on their 
antigenicity and intracellular actin-based motility, rickettsiae were 
initially classified into the typhus group (TG) including R. prowazekii and 
R.  typhi, and the spotted fever group (SFG) which includes more than 20 
different species among which R. conorii and R. rickettsii (Raoult and 
Roux, 1997).  
 
Within the last decade, the availability of complete genome sequences 
of several rickettsial species (Table 1), allowed to gain a better 
knowledge not only about their evolution, but also about their metabolic 
capacities and the molecular mechanisms involved in their pathogenicity 
(Walker 2007; Balraj et al., 2009). Accordingly, besides the TG and the 
SFG a third group including R. bellii and R. canadensis has emerged 
(Blanc  et al., 2007).  
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Table 1.  List of rickettsial genomes sequenced 
 
 
 
Strains Size (Mb) Genbank Reference
R. prowazekii  str. Madrid E 1,11 AJ235269.1 Andersson et al , 1998
R. conorii  Malish 7 1,27 AE006914.1 Ogata et al , 2004
R. typhi  str. Wilmington 1,11 AE017197.1 McLeod et al , 2004
R. sibirica  246 1,25 NZ AABW01000001 Malek et al , 2004
R. felis  URRWXCal2 1,59 CP000053.1 Ogata et al , 2005
R. bellii  RML 369-C 1,52 CP000087.1 Ogata et al , 2006
R. massiliae  MTU5 1,41 CP000683.1 Blanc et al , 2007
R. rickettsii  str. Lowa 1,27 CP000766.1 Hackstadt et al,  2008
R. peacockii  str. Rustic 1,3 CP001227.1 Felsheim et al,  2009
R. africae  ESF-5 1,29 CP001612.1 Fournier et al , 2009
R. prowazekii  Rp22 1,1 CP001584 Bechah et al , 2010
R. heilongjiangensis  054 1,3 CP002912.1 Duan et al , 2011
R. rickettsii  str. Sheila smith 1,26 CP000848.1 Unpublished
R. africae  ESF-5 1,27 NZAAUY01000001 Unpublished
R. akaris  str. Hartford 1,23 CP000847.1 Unpublished
R. bellii  OSU 85-389 1,52 CP000849.1 Unpublished
R. canadensis  str. McKiel 1,16 CP000409.1 Unpublished
R. japonica 1 In progress University of Tokyo
R. prowazekii  str. Madrid E vir 1,3 In progress BCM-HGSC
R. prowazekii  Nuevo Leon Amblyomma tick In progress BCM-HGSC
R. prowazekii Rp22 In progress Unité des Rickettsies
R. sbvaca  13-B In progress Unité des Rickettsies
R. raoultii In progress Unité des Rickettsies
R. sibirica  246 1 AABW00000000 University of Maryland
R. grylli 2 AAQJ00000000 TIGR
R. typhi B9991CWPP In progress Los Alamos National laboratory
R. typhi  TH1527 In progress Los Alamos National laboratory
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The advent of several complete rickettsial genome sequences also 
highlighted the genetic basis for metabolic differences as well as for 
common traits.  Thus, from a careful comparative bioinformatic analysis, 
it was established that rickettsiae contain five autotransporters called the 
surface cell antigen (Sca) family (Blanc et al., 2005). These proteins 
indeed possess 3 domains, a leader sequence that mediates transport 
across the cell membrane, a passenger sequence, and a transporter 
sequence that is inserted as a β-barrel into the outer envelope to transport 
the passenger sequence to the outer surface of the cell wall. In addition to 
the newly identified proteins Sca1, Sca2, and Sca3 that exist as split 
genes (interrupted into 2–4 open reading frames) in at least 1 Rickettsia 
species, this family includes Sca0, previously known as rOmpA and 
present only in the SFG while Sca5 (rOmpB) is present in all Rickettsia 
species. Sca4 (geneD) which shares sequence similarity, is not an 
autotransporter, because it lacks the transporter domain (Blanc et al., 
2005). 
As observed for other intracellular bacteria, rickettsia pathogenicity 
involves sequential steps starting with recognition and adherence to the 
host cells. This crucial step results in the invasion of the endothelial cells 
through induced phagocytosis. Rickettsiae then escape from phagosome 
into the cytosol, where replication takes place leading to direct cell 
damages and death (Balraj et al, 2009). In addition to opening the way for 
bioinformatic analysis, the advances in rickettsial genome sequencing, 
have contributed to improve the knowledge about the molecular 
mechanisms involved in the pathogenicity of these bacteria. Advances in 
the evaluation of the pathogenesis of rickettsial disease include 
identification of rickettsial adhesins, a host cell receptor, signaling 
elements associated with entry of rickettsiae by induced phagocytosis, 
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rickettsial enzymes mediating phagosomal escape, and host actin-based 
rickettsial cell-to-cell spread. 
Two putative rickettsial ligands recognized by host cell surface 
proteins were thus identified. One ligand corresponds to the C-terminal 
extremity of rOmpB called the β-peptide. Other putative ligands are 
proteins of unknown function encoded by the genes RC1281 and RC1282 
in R. conorii as well as by RP827 and RP828 in R. prowazekii and called 
Adr for rickettsial adhesins (Renesto et al., 2006).  The lysis of the 
phagosomal membrane that precedes rickettsia escape into the cytosolic 
compartment was shown to be mediated by the upregulation of genes 
coding for enzymes sharing a membranolytic activity, namely hemolysin 
C (tly C) and phospholipase D (pld) (Renesto P et al, 2003; Whitworth T 
et al, 2005). Historically, the actin-based motility was depicted as a major 
feature allowing to differentiating SFG and TG rickettsiae. Here again, it 
is the comparative analysis of R. prowazekii (TG) and R. conorii (SFG) 
genomes that allowed to identify RickA as a protein endowed for the 
capacity to a promote the polymerization of host cell cytoskeletal actin 
through the activation of Arp 2/3 (Ogata et al., 2001; Gouin et al, 2004), 
an hypothesis recently revisited (Balraj et al., 2008, Kleba et al., 2010). 
Availability of the genome sequences and proteomic approaches also 
favor the development of serological tools including monoclonal 
antibodies (mAbs) which are useful for immunofluorescence-based 
localization and to demonstrate the functional activity selected targets. 
Here, we summarized available data concerning the use of antibodies in 
the field of rickettsiae, either as diagnostic tools or in more basic resaech 
applications.  
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II. AN OVERVIEW OF ANTIBODIES AS USEFUL TOOLS FOR 
DIAGNOSIS OF THE RICKETTSIOSIS AND THEIR CONTRIBUTION 
IN EXPLORATION OF RICKETTSIAL BIOLOGY 
 
II-1. Introduction 
Rickettsiae cause life-threatening rickettsioses which exist primarily 
in endemic and enzootic foci that occasionally give rise to sporadic or 
seasonal outbreaks. Rickettsial pathogens are highly specialized for 
obligate intracellular survival in both the vertebrate host and the 
invertebrate vector. While studies often focus primarily on the vertebrate 
host, the arthropod vector is often more important in the natural 
maintenance of the pathogen. The epidemiology of human diseases 
caused by rickettsiae is intimately related to the biology of the vector that 
transmits (Azad and Beard, 1998). 
Tick-borne rickettsioses are caused by bacteria belonging to the SFG. 
These zoonoses, which are among the oldest known vector-borne diseases 
include the well-known Rocky Mountain spotted fever (R. rickettsii) and 
the Mediterranean spotted fever (R. conorii). More recently, emerging 
SFG rickettsiosis were identified in differents countries and are caused by 
various species as R. japonica (Japan), R. conorii subsp. caspia 
(Astrakhan, Africa, and Kosovo), R. africae (sub-Saharan Africa and the 
West Indies), R. honei (Australia, Tasmania, Thailand), R. slovaca 
(Europe), R. sibirica subsp. mongolitimonae (China, Europe, and Africa), 
R. heilongjanghensis (China and the Russian Far East), R.vaeschlimannii 
(Africa and Europe), R. marmionii (Australia), and R. parkeri (United 
States). The last rickettsia is probably the best illustration, as R. parkeri 
was considered a nonpathogenic rickettsia for more than 60 years. 
Furthermore, the pathogenicity of R. massiliae has been recently 
demonstrated, 13 years after its isolation from ticks. Other recently 
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described rickettsiae, including R. helvetica strains (Europe and Asia) 
have been presented as possible pathogens (reviewed in Parola et al., 
2005). Rickettsiae are transmitted through the tick bite, which generally 
implies that the rickettsiae localize to the salivary glands of the tick. 
Therefore, the precise molecular mechanisms responsible for the 
adaptation of rickettsiae to different host conditions and for reactivation of 
virulence are unknown. 
In contrast to 15 or more validated and/or proposed tick-borne SFG 
species, only three named medically important rickettsial species are 
associated with insects. These insect-borne rickettsiae are comprised of 
two highly pathogenic species, R. prowazekii (the agent of epidemic 
typhus) and R. typhi (the agent of murine typhus), as well as R. felis, a 
species with unconfirmed pathogenicity (Gillespsie et al., 2009). These 
flea- and louse-borne rickettsiae are transmitted to humans through 
contamination of broken skin and mucosal surfaces by infected tick feces. 
Due to its survival in dried louse feces, R. prowazekii can also be 
transferred through aerosols (Bechah et al., 2008).  
In general, and athough the clinical presentations can vary with the 
causative agent, the SFG rickettsiosis syndromes are similar. Among 
common symptoms that typically develop within 1–2 weeks of infection 
are fever, headache, malaise, and sometimes nausea and vomiting. Most 
tick-transmitted rickettsioses are accompanied by a rash or an eschar at 
the site of the tick bite (Parola et al., 2005). The flea-borne disease 
induced by R. typhi present symptoms that are shared with other 
infectious diseases. Most symptoms are nonspecific and require further 
tests to make an accurate diagnosis (Bitam et al., 2008). Except for 
epidemic louse-borne typhus (Bechah et al., 2008), rickettsial diseases 
strike mostly as isolated single cases in any particular neighborhood. 
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Thus, diagnosis of rickettsial infections is often difficult. An history 
of exposure to the appropriate vector tick, louse, flea, or mite is helpful 
but cannot be relied upon. While many rickettsial diseases cause mild or 
moderate illness, epidemic typhus and Rocky Mountain spotted fever can 
be severe and may be fatal in 20%–60% of untreated cases.  
II-2. Antibodies as tools in diagnosis of rickettsiosis 
Among the approaches developped to diagnose rickettiosis are the 
serologic diagnosis, the immunodetection of rickettsiae from blood or 
tissues and the isolation of bacteria. To date, laboratory diagnosis of 
rickettsioses is mainly based on various PCR assays and DNA sequencing 
which allows convenient and rapid identification of rickettsiae, even in 
non referenced laboratories (La Scola and Raoult, 1997).  
 
Serologic diagnosis 
Serological tests are the easiest methods for the diagnosis of tick-
borne rickettsioses. Historically, the rickettsial diagnosis was supported 
by the Weil-Felix test based on the detection of antibodies to various 
Proteus species which contain antigens with cross-reacting epitopes to 
antigens from members of the genus Rickettsia, with the exception of R. 
akari. With the development of techniques for growing rickettsiae, the 
complement fixation test was then adapted for the detection of antibodies 
specific for rickettsiae. A microagglutination test based on the detection 
of interactions between antibodies and whole rickettsial cells was also 
developped.  However, due to the requirement of high amounts of 
purified rickettsial antigens, not available commercially, this method not 
been widely used. Other techniques include the indirect hemagglutination 
and the latex agglutination tests that detect antibodies to an antigenic 
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erythrocyte-sensitizing substance used to coat erythrocytes or latex beads, 
respectively (reviewed in La Scola and Raoult, 1997).  
In the early 1980th, these methods were replaced by others, easier to 
handle and sharing higher sensitivity and specificity, like enzyme-linked 
immunosorbent assay (ELISA) that was first introduced for detection of 
antibodies against R.  typhi and R.  prowazekii (Halle et al., 1977) and 
later adapted to the diagnosis of Rocky Mountain spotted fever (Clements 
et al., 1983). The rickettsial immunofluorescence assay (IFA) adapted to 
a micromethod format is the test of choice for the serodiagnosis of 
rickettsial diseases (Philip et al., 1976). The micro-IFA allows 
simultaneous detection of antibodies against several rickettsial antigens 
starting with a drop of serum in a single well containing multiple 
rickettsial antigen dots.  It is considered as the “gold standard” technique 
and it is used as a reference technique in most laboratories. Western blot 
and line blot assays are also used in routine and is considered as powerful 
serodiagnostic tool for seroepidemiology (Raoult & Dasch, 1995).  
The drawback of ELISA, IFA and western blot, is that all these 
methods require laboratory platforms specialized for culture and 
purification of rickettsiae. Moreover, and while IFA is currently the test 
of choice for serologic diagnosis of rickettsial infection, cross-reactive 
antibodies between rickettsiae species are often observed, rendering 
difficult the serologic identification. 
 
Immunodetection of rickettsiae 
Biopsy specimens of the skin with a rash around the lesion, preferably 
petechial lesions, and tache noire specimens are the most common 
samples used. Immunodetection methods may also be used to detect 
microorganisms from their arthropod vectors. Slides are air-dried and 
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fixed in acetone before being treated with polyclonal or monoclonal 
antibodies conjugated with immunofluorescent labels. 
 
Isolation of rickettsiae 
In the past, only research laboratories that had biosafety level 3 
containment and personnel with extensive experience in cultivating 
rickettsiae were able to isolate these small and strictly intracellular Gram-
negative bacilli from clinical specimens. The centrifugation shell vial, 
technique, first developed for cytomegalovirus culture, was adapted for 
the isolation of R. conorii (Marrero and Raoult, 1989). This method, 
which has led to a significant increase of laboratories suitably equipped to 
isolate rickettsiae, allows detection 48–72 h post-inoculation. Isolation of 
rickettsiae is of great importance as the ultimate diagnostic goal is 
recovery of the bacterial agent from a tick or a patient (La Scola and 
Raoult, 1996).  
 
Molecular methods 
Molecular methods based on PCR and sequencing have enabled the 
development of sensitive, specific and rapid tools for both the detection 
and identification of rickettsiae in blood, skin biopsy specimens, and even 
ticks. Primer sets targeting various rickettsial genes have been described 
and can be used in any laboratory with suitable facilities (Brouqui et al., 
2004; Fournier et al., 2004). 
 
In summary, several diagnostic methods are used for rickettsia 
detection. In the specialized laboratories, shell vial culture, molecular 
biology and serodiagnostic with IFA or adsorbed western blot are used 
systematically. Because it is difficult to diagnose rickettsial infection 
early after infection occurs, administration of antibiotic treatment before a 
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definitive diagnosis is still made (Pelletier and La Scola, 2010).  
Preventive measures are complicated because of the lack of effective and 
safe rickettsial vaccines (Walker, 2007). To detect efficiently bacteria in 
clinical samples, we need to dispose of highly sensitive, specific and 
available detection tests. 
 
III-3. Antibodies as tools for physiopathological investigations  
From the first description of rickettsiae as human pathogens, the 
rickettsiosis remained poorly understood diseases. The use of antibodies 
was helpful to dissect some specific aspects of pathogenesis of these 
obligate intracellular microorganisms. A few examples are detailed 
below: 
 
-Role of rOmpA as a bacterial ligand 
This 190 kDa immunodominant surface-exposed protein is thought for 
long to be involved in adhesion of rickettsiae to host cells, based on the 
protective effect against rickettsial infections in animal models afforded 
by the recombinant truncated rOmpA or DNA plasmid encoding this 
protein (Mc Donald et al., 1987; Li and Walker, 1988; Vishwanath et al., 
1990; Sumner et al., 1995; Crocquet-Valdes et al., 2001). 
Immunoblotting and immunofluorescence assays confirmed the absence 
of rOmpA from R. rickettsii Iowa, as hypothesized from the comparative 
genomic analysis of R. rickettsii Sheila Smith (virulent) and Iowa 
(avirulent) strains that highlighted a deletion resulting in defect of rOmpA 
expression in the latter (Ellison et al., 2008).  
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-rOmpB mediates bacterial invasion and constitutes a protective antigen 
for SFG rickettsiae 
The mammalian receptor Ku70 was identified as involved in the 
rickettsial invasion process, a process where the rickettsial autotransporter 
protein  rOmpB,  intervenes  as bacterial  ligand (Martinez et al., 2005, 
Chan et al., 2009). In a recent paper, Chan et al. (2011) developed mAbs 
which specifically recognize a conformation present in the folded, intact 
rOmpB passenger domain. They demonstrated that such mAbs are 
sufficient to confer immunity in vivo. Analyses in vitro suggest that this 
protection involves a mechanism of complement-mediated killing in 
mammalian blood, a means of rickettsial clearance that has not been 
previously described.  
 
-Sca1 promotes adherence to nonphagocytic mammalian cells 
Bioinformatic analysis of SFG rickettsiae allowed to identify the Sca 
protein family, predicted as outer surface proteins (Blanc et al., 2005). 
However, very little is known about the function(s) of these Sca proteins, 
with the exception of Sca0 (rOmpA) and Sca5 (rOmpB). Western-blot 
and immunofluorescence staining were achieved on R. conorii using a 
polyclonal antiserum directed against the N-terminal portion of the Sca1 
passenger domain (amino acids 29 to 327). Data obtained demonstrated 
that Sca1 is present on the surface of R. conorii isolated from infected 
mammalian cells and involved in their adherence to host cells (Riley et 
al., 2010). 
 
-Evidence for the regulation of rOmpA expression 
During their life cycle, bacteria from the Rickettsia genus may adapt to 
diverse environments in the ticks and mammals. Their adaptation strategy 
most probably results from a selective gene expression, as depicted for 
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other tick-borne pathogens. Accordingly, it was observed, by RT-PCR and 
immunofluorescence assays, that rOmpA expression can undergo major 
changes. Thus, rOmpA is strongly detected when rickettsiae propagated 
within Vero cells while poorly expressed in bacteria collected from tick 
hemolymph (Rovery et al., 2006). Similarly, variation in rOmpA but not 
in rOmpB expression was also evidenced in R. massiliae during the 
Rhipicephalus turanicus life cycle (Ogawa et al., 2006). When inoculated 
from arthropod vectors to human beings, rickettsiae most probably exhibit 
a proteic profile different to that observed from bacteria grown in culture. 
Ex-vivo experiments aimed at characterizing this host-pathogen interaction 
should thus be analyzed with caution. 
 
-The phagosomal escape involves a  rickettsial phospholipase D 
As several other pathogens of the genus Listeria, Shigella and 
Mycobacterium, rickettsiae rapidly gain access to the cytosol of infected 
cells through phagosomal vacuole escape. While the involvement for a 
phospholipase A2 (PLA2) in the entry vesicle lysis was for proposed 
(Winkler and Miller, 1982), the completion of rickettsial genomes 
revealed the absence of PLA2-encoding gene. The first phospholipase 
identified within a rickettsial genome was the R. conorii phospholipase D 
(PLD). Its role as virulence factor was demonstrated through the capacity 
of anti-PLD antibodies to inhibit the cytotoxicity on endothelial cells 
(Renesto et al., 2003). 
These data are summarized Figure 1. 
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Figure 1 
Schematic representation of rickettsia physiopathology 
Rickettsiae express outer membrane proteins including rOmpA, 
rOmpB and Sca1 that are known to be involved in the binding to the host 
cells as it is also the case for Adr2. Their eukaryotic receptors were not 
yet identified, expect for rOmpB thought to interact with the membrane 
protein Ku70. The bacteria then invade human endothelial cells via the 
process of induced phagocytosis and rapidly escape from the phagosome 
into the host cytoplasm. Lysis of phagosome is mediated by bacterial 
membranolytic proteins namely phospholipase D (PLD) and hemolysin 
(tlyC). Thus, bacteria gain the cytosolic compartment and possibly the 
eukaryotic nucleus where they replicate. For rickettsiae exhibiting a 
motile phenotype, cell-to-cell spreading in which RickA was thought to 
play a role is observed while expressed over the entire bacterial surface 
(reviewed in Blaraj et al., 2009). 
Specific events for which experimental investigations were achieved 
using mAbs were pointed out in red. 
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II-4. Monoclonal antibodies – Generalities and future prospects 
Among the techniques employed by pathologists to diagnose and 
study infectious diseases there is a long history of the use of mAbs. MAbs 
are generated in vitro either by hybridoma technology or recombinant 
DNA techniques (Kohler and Milstein, 1975). Briefly, to produce mAbs, 
one removes B-cells from the spleen or lymph nodes of an animal that 
has been challenged several times with the antigen of interest (Figure 2). 
These B-cells are then fused with myeloma tumor cells (hybridomas) that 
can grow indefinitely in culture (myeloma is a B-cell cancer). Large 
amounts of mAbs can thus be produced. The antibodies from the different 
clones are then tested for their ability to bind to the antigen (for example 
with a test such as ELISA) or immuno-dot blot, and the most sensitive 
one is picked out. MAbs can be produced in cell culture or in live 
animals. When the hybridoma cells are injected in the peritoneal cavity of 
mice, they produce tumors containing an antibody-rich fluid called 
ascites. Production in cell culture is usually preferred as the ascites 
technique may be very painful to the animal.  
MAbs are homogenous immunoglobulins that, by definition, 
recognize one epitope and have markedly higher specific activity than 
polyclonal serum. Advantages of mAbs formulations are superior in 
homogeneity, constancy, pathogen specificity, low toxicity, enhancement 
of immune function. Advances in biotechnology have enabled the 
development of antibody-based drugs for use first in treating cancer, and 
recently, for treating infectious diseases. The efficacy of such antibodies 
has been demonstrated in various in vitro studies, animal models and 
clinical trials for a variety of both viral and bacterial pathogens.  
Some concrete and efficient applications concerning the fied of 
rickettsiae are described below. 
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Figure 2  
The different steps of the expression of monoclonal antibodies 
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In this work we first focused our interest on a better characterization of 
R. prowazekii adhesins thought to play a major role in adhesion and host 
cell invasion process. Two distinct adhesins, called Adr1 and Adr2, and 
which display a high sequence homology, were initially taken in 
consideration. However, for unexpected reasons, we failed to express the 
recombinant Adr1 (RP827) as a soluble protein. Only the rickettsial Adr2 
encoded by RP828 was cloned, expressed and purified in amount 
sufficient for immunizations. The production of mAbs was achieved 
through the fusion of mouse myeloma cells and spleen cells from RickA- 
immunized mice. Both sensitivity and specificity of the mAbs anti-Adr2 
were evaluated by western blot. Their efficiency to neutralize R. 
prowazekii entry into host cell was then investigated.  
In the second work, we also generated selective mAbs to gain further 
insights into cell-to-cell spreading, another major event of rickettsia 
pathogenesis. More specifically, our aim was to localize RickA in R. 
conorii. While this protein was found able to promote actin 
polymerisation (Gouin et al., 2004), its role in rickettsia motility has been 
the subject of debates (Balraj et al., 2008; Kleba et al., 2010). Based on 
the lack of peptide signal, its localization as a membrane protein is for 
long questionnable. Immunofluorescence and immune electron 
microscopy are the strategies displayed to carefully examine this aspect.  
In the last part of this work and based on the different potential 
rickettsial recombinant protein markers, we investigated the 
discrimination of infection between R. typhi and R. conorii by ELISA. 
These works were described in the 3 publications presented below. 
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Article 1 – Preamble 
 
Rickettsia prowazekii is the etiologic agent of epidemic typhus and 
Brill-Zinsser disease  (Bechah  et al.,  2008). This is a louse-borne human 
pathogen which has caused large outbreaks in situations where lack of 
hygiene and cold weather favour louse proliferation. Humans are exposed 
to R. prowazekii through direct contact with contaminated body louse 
feces. Rickettsia begins its life cycle in the human host by invading the 
endothelial cells via the process of induced phagocytosis. Then, it rapidy 
escapes from the phagosome into the host cytoplasm where it replicates 
and eventually causes the invaded cell to burst (Walker et al., 2007; 
Balraj et al., 2009).  
Understanding the molecular mechanisms responsible for R. 
prowazekii virulence is an important challenge. Using two dimensional 
polyacrylamide gel electrophoresis (2D-PAGE) combined with high 
throughput matrix-assisted laser desorption/ionization time of fight 
(MALDI-TOF) the first proteome reference maps of both R. conorii and 
R. prowazekii were established (Renesto et al., 2005). This achievement 
in turn led to the identification of two putative rickettsial ligands 
recognized by endothelial cells and called Adr1 and Adr2 (Renesto et al., 
2006).  
Recognition of and binding to the host cell is a key step for 
pathogenesis. This is particularly true when considering the fact that these 
strictly intracellular bacteria must enter host cells to replicate and survive.  
Here, in order to get better knowledge about the rickettsial Adr2 adhesin, 
we produced mAbs directed against this protein. For this purpose, the 
recombinant Adr2 protein from R. prowazekii was cloned, expressed and 
purified to immunize mice. The capacity of the anti-Adr2 mAb to inhibit 
rickettsiae-induced cytotoxicity was also investigated.  
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Article 1  
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1. Introduction 
Rickettsia prowazekii is the etiological agent of epidemic typhus. This 
bacterium is an obligate intracellular parasite that grows freely within the 
cytoplasm of its eukaryotic host cell rather than in phagosomes or 
phagolysosome [1]. R. prowazekii can be isolated from shell vial cell 
cultures, which has replaced classic animal- and/or embryonated egg–
based culture methods [2, 3]. The pathogen exhibits a slow generation 
time (8–12 h), undergoes steady multiplication and lyses the host cell by 
releasing hundreds of infectious bacteria [3]. Understanding the 
mechanisms involved in this unique intracytoplasmic parasitism was the 
goal of current study. 
 Bacterial cell surface proteins are involved in host-parasite 
interactions and are targeted by the adaptive response of the host immune 
system [4]. Adhesion is a key step for bacterial invasion of host tissues, 
and adhesins are bacterial surface proteins that recognize receptors on 
host cells. The expression of various genes during adhesion can activate 
the pathogenic process [5]. Proteins as well as structural organelles on 
bacterial surface mediate adhesion. The bacterial components may be 
capsule, lipopolysaccharide, toxins and adhesins.  
The R. japonica rOmpB autotransporter proteins function in 
rickettsial adherence to and invasion of Vero cells [6]. These proteins 
belong to a large family of outer membrane proteins known as the surface 
cell antigen (Sca) family [7]. Rickettsial entry into the host cell is 
mediated by the rOmpB protein, which binds to the host cell receptor 
Ku70, a component of the DNA dependent protein kinase [8]. Cholesterol 
also acts as a membrane receptor for R. prowazekii binding [9-12]. The 
rOmpA protein is an immunodominant, surface-exposed autotransporter 
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present only in the rickettsial spotted fever group [12, 13] and may be 
involved in the initial adhesion of R. rickettsii to the host cell [14]. In the 
previous study, two putative rickettsial ligands recognized by host cell 
surface proteins were identified using high resolution 2D-PAGEcoupled 
with mass spectrometry [15]. The results showed that one ligand 
corresponds to the C terminal extremity of rOmp B called β-peptide, the 
second one being a protein of unknown function encoded by RC1281 in 
R. conorii. RC1281 is located downstream of its paralog, RC1282 [15]. 
Their orthologous genes in R. prowazekii are respectively RP827 and 
RP828 encoded proteins share striking homologies. They are respectively 
termed Adr1 and Adr2 for adhesion of Rickettsiae. Because of the 
presence of a signal peptide in Adr1 and Adr2 and their significant 
sequence homology with membrane proteins, they likely form a β barrel 
structure within the outer membrane, a location consistent with their 
putative function as adhesins. Adr1 and Adr2 are ubiquitously present 
within the Rickettsia genus and may play a critical role in their 
pathogenicity. However, the precise role of these proteins has not been 
investigated [15]. 
 First, our attention was to characterize the role of these two adhesins 
Adr1 and Adr2 in rickettsial entry mechanisms to the host cell. However, 
we failed expression of recombinant protein Adr1 (RP827) and only the 
rickettsial gene Adr2 (RP828) could be cloned, expressed and purified in 
the amounts sufficient for mice immunizations. We produced monoclonal 
antibody (mAb) anti-Adr2 which was used to determine the neutralizing 
effect of R. prowazekii entry into host cell. 
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2. Results 
2.1. Distribution of Adr1 and Adr2 within bacterial species 
The sequence similarities of the putative adhesins Adr1 and Adr2 for 
all studied rickettsial species are shown in Suppl. M1. Adr1 and Adr2 are 
conserved across all rickettsial species, and the highest sequence 
similarity was found between R. sibirica and R. africae Adr1 (98%) and 
between R. sibirica and R. rickettsii Adr2 (99%). The similarity between 
Adr1 and Adr2 sequences was about 40% among all rickettsial species. 
When comparing the rickettsial ORFs (Open Reading Frame) coding for 
Adr1 and Adr2 against the NCBI database, using the blastP software, we 
found that these proteins have homologs in other bacterial species (more 
than 30% amino acid sequence identity) (Fig. 1). These homologs were 
found predominantly among the α-proteobacteria, but were also identified 
in γ-proteobacteria such as Escherichia spp. and Salmonella spp. (Fig. 1). 
 
2.2. Identification of the rickettsial adhesins using the overlay assay 
To identify proteins expressed on the surface of R. prowazekii, an 
overlay assay was used. As illustrated in Fig. 2, this technique allows for 
the localization and identification of the rickettsial adhesins. Adr1 
(RP827) and Adr2 (RP828) have a theoretical molecular weight of 23 
kDa and 26 kDa, respectively. To further characterize the adhesins, the 
separation of the protein was carried out in 2D-PAGE and detected by 
silver staining. Following silver staining (Fig. 2A), intensely stained 
protein spots were excised from the gel, and matrix-assisted laser 
desorption ionization time of flight mass spectrometry (MALDI-TOF 
MS) was used for identification and analysis. A comparison of the 2D-
gel/MALDI-TOF MS analysis and the overlay assay demonstrated that 
the spots identified in both methods were the presumed adhesions in R. 
prowazekii, RP827 and RP828. Interestingly, we have missed 
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identification of RP827 in Rprowazekii and homolog of RP828 in R. 
conorii [15]. We identified RC1281 which shares sequence homology 
with RP827 and sca5 (β-peptide) respectively in R. conorii. Only RP828 
and β-peptide were identified in R. prowazekii. Moreover, we identified 
immunoreactive spot m1 which corresponds to prohibitin-2 (Mus 
musculus), but failed identification of other 2 immunoreactive spots m2, 
m3. Thus, this work completes and confirms previous results [15]. 
 
2.2.1. Cloning, expression and purification of rickettsial adhesins 
Initially, two R. prowazekii genes encoding Adr1 and Adr2 were 
selected for cloning and expression experiments by using Gateway 
technology (Invitrogen, Carlsbad, CA, USA). However, despite using 2 
different constructions (with N terminal Histag -DsbC and Histag-
thioredoxine fusion), we have successfully attempted the expression of 
only one protein of R. prowazekii. Thus, Adr2 was purified in soluble 
form in sufficient yield by a Nickel affinity chromatography (suppl. M2) 
for further experiments. In the case of two different Adr1constructions the 
cloning was successful, but expression of recombinant fusion proteins 
(Dsbc- Adr1, trx-Adr1 and trx-Adr2) in E. coli Rosetta (DE3) pLysS 
strain failed. The migration profile of the recombinant fusion protein is 
shown in Fig. 3A (Coomassie staining) showing DsbC-Adr2 fusion 
protein about 55 kDa, which corresponds to 26 kDa Adr2 protein in 
fusion with DsbC (28.4 kDa). The identity of recombinant protein Adr2 
was confirmed by western blot using an anti-His antibody (Fig. 3B) and 
by MALDI-TOF MS, respectively.  
The genes encoding: groEL and RP059 were subsequently cloned 
according to manufacturer’s instructions (Gateway Cloning 
Technology/Invitrogen Life Technologies). Then, expression of clones 
containing an N-His6 tag plus a fusion protein thioredoxin (TRX) [16] 
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that enhances expression of the fusion partner [17, 18] was performed as 
described below. The identity of these proteins was checked by MALDI-
TOF as described for Adr2. Purified recombinant proteins were used to 
generate mAbs included as controls in 137 neutralization assay (see 4). 
 
2.3. Production of monoclonal antibodies against Adr2 
Monoclonal antibodies (mAbs) were generated against the recombinant 
R. prowazekii Adr2. The antigenic profile of the recombinant protein was 
analyzed using western blots and silver staining. In a western blot, the 
monoclonal antibody obtained from immunized mice with R. prowazekii 
Adr2, recognized proteins at the positions corresponding to the theoretical 
location of Adr2 (Fig. 4A). The corresponding silver-stained spot was 
identified by MALDI-TOF MS (Fig. 4B) as Adr2 protein. 
 
2.4. Inhibition of R. prowazekii-induced cytotoxicity with anti-Adr2 
monoclonal antibody 
When R. prowazekii was pretreated for 20 min with increasing titers 
of anti-Adr2 monoclonal antibody and then added to L929 cells, cell 
cytotoxicity measured after 1h of incubation was 37% (dilution 1:100) 
and 40% (dilution 1:10), respectively. At the same time of sampling, 
inhibition of rickettsial entry assessed by rOmpB mAb was 53% (dilution 
1:10) and 33% (dilution 1:100), respectively (Fig. 5). The % of inhibition 
assessed by negative specificity controls was about 5% for both mAbs: 
groEL and RP059. However, the greatest value of inhibition was obtained 
for 8h sample with the % of inhibition for Adr2 about 50% (dilution 1:10) 
and 43% (dilution 1:100). Indeed, the values obtained for rOmpB were 
57% (dilution 1:10) and 43% (dilution 1:100). This inhibition was 
antibody concentration dependent for both Adr2 and rOmpB at 8h of 
incubation. Indeed, the % of inhibition was less than 10% for both 
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controls: GroEL and RP059. We observe decreased % of inhibition for 
both rOmpB and Adr2 at the time of sampling 24h, 120h and 168h and 
ranging from 38% to 18% (Adr2, dilution 1:10), from 36% to 8% (Adr2, 
dilution 1:100) and 48% to 36% (rOmpB, dilution 1:10), 42% to 17% 
(rOmpBdilution 1:100), respectively. No significant variation was 
observed for GroEL and RP059, except at 24h time of sampling, the 
inhibition was 20% for groEL. The negative control consists on 
uninfected cells incubated with buffer only and showed noisy background 
of non specific cytotoxicity which ranged about 30%. In addition, Adr2 is 
sufficient to mediate R. prowazekii entry into the cell at early stage of 
mammalian cell infection. 
 
3. Discussion 
In the present study, first, we selected in R. prowazekii genome the 
genes encoding for Adr1 (RP827) and Adr2 (RP828) based on previous 
work [15], sequenced and constructed the phylogenical tree showing the 
distribution of putative Adr1 and Adr2 within bacterial species including 
Rickettsiae, α- and γ-proteobacteria. Secondly, we identified in R. 
prowazekii proteome adhesins Adr1 and Adr2 and showed inhibition of 
R.prowazekii entry into the host cells by using monoclonal antibodies 
generated by mice immunization with recombinant fusion protein Adr2-
Dsbc, rOmpB [19], as well as with recombinant proteins TRX-GroEL 
(RP626) and TRX-spo0J (RP059), respectively. All examined Rickettsia 
spp. share these both adhesins (Suppl. M1). Previous studies reported 
other adhesins differentially expressed in Rickettsia like the surface cell 
antigen (sca) family proteins and the outer membrane proteins, rOmpA 
and rOmpB [14, 20]. These genes have been used to study the 
phylogenetic relationships between Rickettsia spp. The Adr1 and Adr2 
gene sequences show some heterogeneity between Rickettsia spp., in 
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accordance with the four distinct rickettsial groups (e.g., the spotted fever 
group, the typhus group, R. canadensis and R. bellii). A highly resolved 
phylogenetic tree at the group level was constructed using the RP828 
sequences (Fig. 1).We used overlay assays along with a proteomic 
approach to identify the adhesins [21]. From a crude extract, proteins 
were separated using 2D-PAGE with 6–11 strips (Fig. 2), which allowed 
for better resolution of the protein than the previously optimized 
conditions [15]. This approach allows for the localization and 
identification of the rickettsial adhesins using MALDI-TOF MS. Both 
RP827 and RP828 were detected. We observed the same pattern of results 
using the overlay assay, as seen in Fig. 2. Therefore, the protein 
identification was confirmed using both an overlay assay and western 
blot.  
The expression and purification of recombinant Adr2 (RP828) was 
performed as previously described [18]. Rickettsiae are obligate 
intracellular growth requirement of the bacteria poses a challenging 
obstacle to their genetic manipulation [22, 23]. Numerous expression 
vectors are available, and the choice of a vector depends upon the protein 
to be expressed [22]. We have tested two different constructions in our 
study: protein in fusion with DsbC and Trx, respectively. Only this DsbC 
-RP828 could be expressed in vivo. We have also chosen an improved E. 
coli strain for codon usage (Rosetta pLysS). Rare codons are not only 
strongly associated with low yield of protein expression due to ribosome 
stalling and abortive translation [24, 25], but also implicated in frameshift 
and amino acid misincorporation [26]. Despite all these efforts to 
overcome technical limitations, from both selected initially adhesins 
(RP827 and RP828), we have successfully attempted the expression of 
only RP828 in fusion with DsbC. The purification of a soluble RP828 in 
large amounts required for mice immunization, has also revealed a 
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difficult task, but finally achieved by using nickel affinity 
chromatography.  
BLAST and phylogenetic analyses demonstrated that RP827 and 
RP828 have homologs in other bacteria from different phyla. Some of 
these bacteria, such as Brucella spp. and Salmonella spp., are intracellular 
pathogens that bind to and enter the host cell. Adhesins have been shown 
to play a major role in the early steps of infection: they target a host cell 
receptor, allowing the bacteria to colonize or become internalized in the 
host cell. Thus, adhesins are mainly involved in interactions with the host 
cell to promote entry [27]. However, the inhibition of rickettsiae induced 
cytotoxicity with monoclonal anti-Adr2 antibody has showed a greatest 
impact on bacterial cell entry at 8h post- infection (around 50% of 
inhibition) and then decreased progressively to attempt 18% of inhibition 
at day 7. These, correlated to the inhibition of rickettsiae-induced 
cytotoxicity with monoclonal anti-rOmpB antibody. Thus, Adr2 is 
sufficient to mediate R. prowazekii entry into the cell at early stage of 
mammalian cell infection. However, the method used in this work 
allowed only global appreciation of this phenomenon and remains the 
focus on more detailed mechanisms of further studies. Thus, this result is 
expected if we consider rOmpA, rOmpB and RP827 are also involved in 
entry mechanisms of Rickettsiae into the host cell. Thus far, rOmpA 
(sca0) and rOmpB (sca5), have been shown to participate in adhesion of 
Rickettsiae to mammalian cells in vitro [8, 14, 20, 28]. Recently, 
Cardwell et al., [29] shown that Sca2 protein is sufficient to mediate 
adherence to and invasion of R. conorii infected cultured mammalian 
epithelial and endothelial cells. Inhibition (ca 30%) of these phenotypes 
with purified soluble Sca2 protein confirms that invasion of host cells is 
specifically mediated by Sca2 [29]. However, the % of protein sequence 
identity is about 25% for R. typhi, which is like R. prowazekii belongs to 
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Typhus group (TG) [29]. Its role within TG remains to be elucidated. The 
ability of R. prowazekii to induce internalization into mammalian cells is 
likely governed by numbered adhesin-receptor interactions which 
involved several partners as RP827, RP828, rOmpB proteins, Sca2 
protein (Fig. 6). Indeed, the identification of mammalian receptors 
involved in adhesins-mediated uptake of mammalian cells is should be 
undertaken in ongoing studies.  
Monoclonal antibodies against adhesins are an excellent tool to study 
these interactions between rickettsial adhesins and host mammalian 
receptors, may also be an efficient therapeutic agent to block binding to 
target cells and inhibit bacterial entry into the host cell. NadA-specific 
antibodies have been effective in the control of N. meningitidis [30]. 
Rickettsial surface proteins have been used to produce monoclonal 
antibodies that conferred protective immunity in guinea pigs and mice 
[14]. In addition, prophylactic vaccination with adhesins can prevent 
bacterial infection [31]. Despite that the monoclonal antibodies against 
RP828 produced in this study have not inhibited efficiently the 
adhesion/entry of Rickettsia to the host cell; however, the further 
orientations should focus on infectivity neutralization assays in vivo. 
Monoclonal antibodies may also be used to elucidate the Rickettsial 
physiological and pathological mechanisms. In Orientia tsutsugamushi, a 
monoclonal antibody was used to characterize its life cycle in endothelial 
cells [30]. Adr1 and Adr2 may act as broad-spectrum vaccine targets for 
all Rickettsia spp. since they are well conserved in the Rickettsia spp. 
examined. 
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4. Conclusion 
Adhesion and invasion are the crucial stages of obligate intracellular 
infection of host cells, and adhesins are critical in bacterial virulence. We 
shown that Adr2 is probably one of several factors involved in 
adhesion/entry of R. prowazekii into host cell. Further investigations 
involving Adr2 and other adhesins may lead to the development of 
antimicrobials to prevent the emergence and recurrence of infections. 
 
5. Materials and Methods 
5.1. Propagation of R. prowazekii and DNA purification 
R. prowazekii (URRPM22) was propagated at 32°C in monolayers of 
murine fibroblast L929 cell (ATCC CCL 1, European Collection of Cell 
Cultures 85011425) in Eagle’s minimum essential medium (MEM, 
Invitrogen, Paisley, UK) supplemented with 2% fetal bovine serum (FCS, 
Gibco) and 2% L-glutamine (Gibco). Total genomic DNA was extracted 
from infected cells using the QIAamp DNA Mini Kit (Qiagen, Hilden, 
Germany). 
 
5.2. Cloning 
The R. prowazekii RP827 , RP828, groEl, RP059 genes were 
amplified using primers designed for Gateway cloning (Table 1) and the 
Expand High Fidelity PCR System (Roche Diagnostics, Maylan, France). 
Genes were amplified with 30 cycles of denaturation for 30 sec at 94°C, 
annealing for 45 sec at 50°C and elongation for 2 min at 68°C, followed 
by termination for 5 min at 68°C in a PE 9600 thermal cycler (Applied 
bio systems, Courtaboeuf, France). The resulting PCR products were 
purified through PEG precipitation and inserted into the pDONR201 
vector (Gateway Cloning System, Invitrogen, USA) by the BP 
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recombination reaction, and according to the manufacturerۥ s instructions. 
The products of the recombination reactions were transformed into 
competent DH5α cells and selected on LB-agar plates containing 
kanamycin (50 µg/mL). Clones were confirmed using sequencing and the 
dRhodamine Terminator Cycle Sequencing Ready Reaction Kit (Applied 
Biosystems, Foster City, Ca, USA). The second step of Gateway cloning 
was gene transfer into a destination vector (pDest17) by the LR reaction 
(Gateway Cloning System, Invitrogen, Carlsbad, CA, USA). The 
resulting expression plasmids were transformed into competent DH5α 
cells, selected on LB-agar plates with ampicillin (50 µg/mL) and 
confirmed by PCR. 
 
5.3. Expression and purification 
The expression and purification of recombinant proteins were 
performed as previously described [18, 32]. Briefly, the plasmids 
encoding Adr1 or Adr2, as well as groELand RP_059 were used to 
transform E. coli strain Rosetta (DE3) pLysS (Novagen, Madison, WI, 
USA). For expression of the recombinant proteins, bacteria were grown 
in the auto-induction medium ZYP5052 (1.4 liters) at 37°C for 4 h at 200 
rpm [33]. Following this incubation, the temperature was lowered to 
17°C, and the cells were pelleted after 18 h. The bacterial pellet was 
resuspended in lysis buffer (50 mM Tris, 300 mM NaCl, 10 mM 
imidazole pH 8.0, 0.25 mg/ml lysozyme and 1 mM PMSF) and frozen at -
80°C for at least 1 hour. After thawing the bacterial pellets and adding 
DNAse I (2µg/ml) and MgSO4 (20 mM), the lysed cells were centrifuged 
to separate the soluble fraction from the bacterial debris. The protein was 
purified using a nickel affinity column. For this purpose, the supernatant 
containing the recombinant protein DsbC-Adr2 was loaded on a 5-ml 
HisTrap crude nickel column (GE Healthcare, Chalfont St. Giles, UK) 
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equilibrated in buffer A (50 mM Tris pH 8.0, 300 mM NaCl and 10 mM 
imidazole) (Suppl. M2). The column was then washed with five volumes 
of buffer B (buffer A with 500 mM imidazole) to remove endogenous 
nickel-binding proteins. The protein was eluted with buffer C (buffer A + 
250 mM imidazole). The protein-containing fractions were pooled and 
stored in 50% glycerol at -20°C. The identity of the isolated protein was 
confirmed using mass spectrometry. 
 
5.4. Production of mAbs against Adr2 (RP828), rOmpB, groEL and stage 
sporulation protein (RP059) 
The monoclonal antibody (MAb) rose against rOmpB was produced 
as previously described [19]. The remaining MAbs were produced by 
inoculation of 6- to 8-week-old immunocompetent BALB/c mice 
(Charles River Laboratories, St. Aubin Les Elbeuf, France) with a total of 
25 µg of purified recombinant proteins Adr2, groEL, RP059 respectively, 
with CpG adjuvant, respectively, as described previously [34,35]. Three 
days after the last injection, the mice were euthanized, and the spleen was 
removed aseptically. Splenocytes were isolated and prepared for fusion 
with mouse myeloma cell line NS-1, as described [35]. Hybridoma clones 
were selected in RPMI medium (Invitrogen, Carlsbad, CA, USA) 
containing 15% FCS supplemented with HAT medium (Invitrogen, 
Carlsbad, CA, USA). Colonies were screened using an ELISA after 10 
days. The isotypes of the MAbs were determined with an ImmunoType 
Mouse Monoclonal Antibody Isotyping kit with antisera to mouse 
immunoglobulin M (IgM), IgA, IgG1, IgG2a, IgG2b, and IgG3 (Sigma 
ChemicalCo.). The antiserum was affinity- purified by use of 
MAbTrap™ Kit (GE Healtcare) according to the manufacturer’s 
instructions. Serum levels of of recombinant protein-specific IgG was 
determined by ELISA, as previously described [35]. The higher dilution 
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of each affinity- purified antibody recognizing the recombinant protein 
was estimated. In parallel, the protein content in eluted fraction was 
estimated by modified Bradford method (Bio-rad), as previously 
described [37]. The protein concentration in elution fraction was: 11.96 
µg/ml (Adr2), 8.39 µg/ml (rOmpB), 8.23 µg/ml (GroEL), 9.37 µg/µl 
(RP059) respectively. The specificity of mAbs raised against groEl and 
RP059 was assessed by immunoblotting (Suppl.M3). 
 
5.4.1 ELISA 
ELISAs was performed as previously described [36] with minor 
modifications. Microtiter plates were coated seperatly with 40 µg of each 
recombinant protein from this study in 100 µl of carbonate buffer 
overnight at 4°C. The coated wells were washed with phosphate buffered 
saline (PBS) containing 0.05% Tween 20 and blocked with 100 µl of 3% 
non-fat milk in PBS for 1 hr at room temperature (RT). Hybridoma 
supernatant (50 µl) was then added as a primary antibody and the plates 
were incubated for 1 hr at RT before washing with PBS supplemented  
with 0.1% Tween 20. Following the washes, 100 µl of goat anti-mouse 
biotin was added, and the plates were incubated for 1 hr at RT washed 
with 0.1% Tween 20 in PBS. The plates were then incubated with 
streptavidin for 1 hr and washed with 0.1% Tween 20 in PBS. Following 
this wash, 100 µl of ortho-phenylenediamine (OPD) was added, and the 
plates were incubated for 2–3 min at RT. After 10 min of incubation with 
OPD at room temperature, the reaction was stopped with 100 mL/well 
NaOH 1 M. Color development was assessed with a microplate reader 
(Multiskan EX, Labsystems, Thermo Fisher Scientific, Waltham, MA) at 
a wavelength of 490nm. Any samples exhibiting absorbance above or 
similar to the positive control was considered as positive. A positive 
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control consisted in polyclonal positive serum of R. prowazekii and a 
negative control consisted in pre-immune negative serum. 
 
5.5. Sample preparation for 2D-electrophoresis 
R. prowazekii RP22 was propagated in a confluent monolayer of 
murine fibroblast L929 cell line and purified on a renografin gradient as 
previously reported [37]. Purified bacteria were lysed by sonication in a 
solubilizing buffer (7 M urea, 2 M thiourea, 30 mM Tris, 4% w/v 
CHAPS) and centrifuged (10,000×g, 20 min, 4°C) to remove cell debris 
and unbroken cells. Soluble proteins were precipitated using the PlusOne 
2-D Clean-Up Kit (GE Healthcare, Chalfont St. Giles, UK). The final 
pellet was resuspended in solubilizing buffer, and the protein 
concentration was determined using the Bio-Rad DC Protein Assay. 
 
5.5.1. 2D electrophoresis and silver staining 
Immobiline DryStrips gels (13 cm, pH 6–11, GE Healthcare, Chalfont 
St. Giles, UK) were rehydrated overnight in 250 µl rehydration buffer (7 
M urea, 4% w/v CHAPS, 12 µl/ml DeStreak, 0.5% v/v immobiline pH 
gradient (IPG) buffer (GE Healthcare, Chalfont St. GilesUK) containing 
30 µg of solubilized proteins. IEF was carried out according to the 
manufacturer’s protocol (IPGphor II, GE Healthcare, UK). Prior to 
electrophoresis in the second dimension, the strips were equilibrated for 
15 min in equilibration buffer (30% v/v glycerol, 2% w/v SDS, 6 M urea, 
50 mM Tris-HCl, bromophenol blue, pH 8.8) containing 65 mM DTT. 
This step was then repeated using equilibration buffer supplemented with 
100 mM iodoacetamide. The strips were then embedded in 0.5% agarose, 
and the proteins were resolved by electrophoresis through a 10% SDS-
polyacrylamide gel (EttanTM DALT, GE Healthcare, Chalfont St. Giles, 
UK) at 5 W/gel for 30 min, followed by 17 W/gel for 4–5 h. Following 
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electrophoresis, the gels were silver-stained, and digital images were 
generated using transmission scanning (ImageScanner, GE Healthcare, 
Chalfont St. Giles, UK) to identify the proteins. Spots excised from the 
gel were identified using MALDI-TOF MS and a Bruker Ultraflex 
spectrometer (Bruker Daltonics, Wissembourg, France) as described 
previously [38]. 
 
5.5.2. Overlay Assay 
Overlay assays were performed as previously described [15]. R. 
prowazekii extracts (30 µg) were separated using 10% SDS-PAGE. Both 
silver staining and an overlay assay were then performed. Resolved 2D 
gels were transferred onto nitrocellulose membranes (Trans-Blot transfer 
medium, pure nitrocellulose membrane, Bio-Rad, Hercules, CA, USA) 
for 2 h using a semi-dry transfer unit (Hoefer TE 77, GE Healthcare, 
Chalfont St. Giles, UK). Membranes were blocked in PBS supplemented 
with 0.2% Tween 20 and 5% non-fat dried milk (PBS-Tween- Milk) for 
1.5 h. After blocking, the membranes were incubated for 1.5 h at 4°C 
with biotinylated Vero cells (1:100). The reactive spots were detected 
using peroxidase-labeled streptavidin (1:1000; Becton-Dickinson, San 
Jose, CA) and chemiluminescence (ECL; GE Healthcare, Chalfont St. 
Giles, UK).  
 
5.6. Western blot 
Following the transfer of rickettsial proteins, the nitrocellulose 
membranes were blocked in PBS-Tween-Milk for 1 h before incubation 
with the serum of a mouse immunized with recombinant Adr2 (1:100 
dilution in PBS-Tween-Milk). Following a1 h incubation, the membranes 
were washed three times for 10 min in 0.2% PBS-Tween-20 and probed 
with a 1:1000 dilution of a horseradish peroxidase–conjugated goat anti-
 55
mouse secondary antibody (GE Healthcare, Chalfont St. Giles, UK). The 
blots were washed with 0.2% Tween 20 in PBS, and chemiluminescence 
was used to detect protein bands (ECL, GE Healthcare, Chalfont St. 
Giles, UK). The resulting signal was detected on Hyperfilm ECL (GE 
Healthcare, Chalfont St. Giles, UK) using an automated film processor 
(Hyperprocessor, GE Healthcare, Chalfont St. Giles, UK). We used to 
work with freshly transferred proteins into the nitrocellulose membrane. 
We have never used twice the same membrane for Western blotting 
experiments. 
 
5.7. Inhibition of R. prowazekii-induced cytotoxicity on L929 cells 
L929 cells grown in MEM supplemented with 4% fetal calf serum 
and 2 mmol/L L-glutamine, in microtiter plates, were inoculated with 
3000 pfu of R. prowazekii/well [35, 39]. To examine whether Adr2 
monoclonal antibody could inhibit the cytotoxicity of R. prowazekii, 
bacteria purified on sucrose gradient were incubated for 20 min at 4°C, 
with increasing dilutions of antibody, before incubation with L929 cells 
[35]. After 1h, 8h, 24h, 120h (5 days) and 168h (7 days) of incubation at 
37°C in 5% CO2, the cell culture supernatant was removed, and cell 
monolayer were incubated for 1h at 37°C with 50 µl of neutral red dye 
(0.15% in saline [pH 5.5]). The viability of bacteria has been checked by 
inoculation of cell monolayer with the remaining cell culture supernatant. 
The same conditions were applied for specificity controls: (i) positive 
control performed with rOmpB mAb [19], which is known that rOmpB 
protein is involved in rickettsial entry [12], (ii) negative controls 
performed with mAbs raised against GroEL and RP059 which are most 
likely do not involved in cell cytotoxicity. Dye not absorbed by the viable 
cells was removed by 2 washes with PBS (pH 6.5). Finally, the dye 
absorbed by the cells was extracted by the addition of 100 µl of ethanol in 
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PBS (pH 4.2), and the optical density at 492nm was measured with a 
microplate reader (Multiskan EX, Labsystems, Thermo Fisher Scientific, 
Waltham, MA). At least three independent assays were performed. The 
results were expressed as a percentage of cytotoxicity obtained with R. 
prowazekii incubated with the buffer alone. The graphs were compiled 
with GraphPad Prisme software (version 3.0, GraphPad Software, San 
Diego, CA, USA). 
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Figure 1 
Distribution of Adr1 and Adr2 in bacterial species 
Rickettsial Adr1 (RP827) and Adr2 (RP828) ORFs were compared 
against the NCBI database using the BLASTP software, and homologs in 
other bacterial species were identified and it was shown in phylogenetic 
tree. 
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Figure 2 
Recognition of adhesins Adr1 and Adr2 using the overlay assay 
Rickettsial proteins were separated in the first dimension over a pH 
gradient (pH of 6–13) and then separated using SDS-PAGE in the second 
dimension. The 2D gel was silver stained for MS based identification of 
the spots (A) or transferred to a nitrocellulose membrane and subjected to 
an overlay assay (B). 
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Figure 3 
Purification of the rickettsial adhesin Adr2 
During the purification process, different fractions of the protein extract 
were separated using SDS-PAGE and stained with Coomassie blue (A). 
The identity of purified protein was confirmed using western blot with an 
anti-his antibody (B). T = Total, S = Soluble, W = Wash, E = Elution. 
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Figure 4 
 Specificity of monoclonal antibodies against Adr2 
Detection of rickettsial Adr2 (RP828) using monoclonal antibody 
obtained from immunized mice. The R. prowazekii protein sample was 
separated using 2D-electrophoresis and visualized using silver staining 
(B) or western blot with anti- Adr2 (RP828) monoclonal antibody (A) 
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Figure 5 
Inhibition of R. prowazekii MadridE-induced cytotoxicity with anti-
Adr2 monoclonal antibody 
R. prowazekii MadridE (3x103 bacteria per well) was pretreated for 20 
min with increasing titers of anti -Adr2 (RP828), anti-rOmpB, anti-groEL 
and anti-RP059 mAbs before infection on L929 cells at the sampling 
points post-infection: 1h, 8h, 24h, 120h (5 days) and 168h (7days). The 
percentage of remaining viable L929 cells was estimated by staining with 
neutral red at each time of sampling. To estimate the relative cytotoxicity 
levels, the cytotoxicity level of R. prowazekii MadridE pretreated with 
buffer alone was considered to be 100%. The negative control consists on 
uninfected stained L929 cells. The % of inhibition of rickettsial 
cytotoxicity was calculated for each mAb. 
 
 
 64
Figure 6 
Model of R. prowazekii interaction with mammalian cells 
The rickettsial entry to the host cell is likely governed by interactions 
between rOmpB and its receptor Ku70, most likely by the adhesins Adr1 
and Adr2, by unknown mechanism. Based on the model of SFG 
Rickettsiae, we can suppose that Sca2 is also involved in bacterial entry; 
however, Sca2 of TG shares only 25% of homology with SFG Sca2 
protein. Mammalian cholesterol is involved in bacterial interaction. 
Following rickettsia entry into host cells through induced phagocytosis, 
bacteria rapidely escape from the vacuole (possible role of PLD, TlyC) to 
gain the cytosolic compartiment and possibly the nucleus of mammalian 
cell where R. prowazekii replicates. The mechanism of cell-to-cell 
spreading for immobile TG Rickettsiae remains unknown. The rickettsial 
secretion system T4SS translocates effectors that should contribute to the 
intracellular survival of R. prowazekii.  
 
 
 
Table 1 
 
Gene Protein Strain Primers used
RP827 Dsbc-Adr1 MadridE/RP22 F:5'-GGGG ACA AGT TTG TAC AAA AAA GCA GGC Ttcgatcatgatatgaattgttctgtag -3'
R:5'-GGGG AC CAC TTT GTA CAA GAA AGC TGG GTC CTA catatcaaatcttaatcctgccattaag- 3'
RP828 DsbC-Adr2 MadridE/RP22 F:5'-GGGG ACA AGT TTG TAC AAA AAA GCA GGC Ttcgagtgcattgataatgaatgg- 3'
R:5'-GGGG AC CAC TTT GTA CAA GAA AGC TGG GTC CTAtataccaaatcttacacctactgtc- 3'
RP827 TRX-Adr1 MadridE/RP22 F:5' GGGGACAAGTTTGTACAAAAAAGCAGGCTTAGAAAACCTGTACTTCCAGGGT-GATCATGATATGAATTGTTCTGTAGATTCA-3'
R:5'- GGGGACCACTTTGTACAAGAAAGCTGGGTCttatta- CATATCAAATCTTAATCCTGCC- 3'
RP828 TRX-Adr2 MadridE/RP22 F:5' GGGGACAAGTTTGTACAAAAAAGCAGGCTTAGAAAACCTGTACTTCCAGGGT-GAGTGCATTGATAATGAATGG- 3'
R:5'- GGGGACCACTTTGTACAAGAAAGCTGGGTCttatta-TATACCAAATCTTACACCTACTGTC-3'
60 KD 
CHAPERONIN
(groEL) RP626 TRX-groEL MadridE F:5'-GGGGACAAGTTTGTACAAAAAAGCAGGCTTAGAAAACCTGTACTTCCAGGGT-ACAACGAAACTTATTAAACACG-3'
R:5'-GGGGACCACTTTGTACAAGAAAGCTGGGTCttatta-GAAGTCCATACCACCCATGCCAC-3'
Stage 0 
sporulation
protein J (spo0J) 
RP059 TRX-spo0J MadridE F:5'-GGGGACAAGTTTGTACAAAAAAGCAGGCTTAGAAAACCTGTACTTCCAGGGT-GTGAAAAATAAAGGGCTAGGGC-3
R:5'-GGGGACCACTTTGTACAAGAAAGCTGGGTCttatta- ATTTAATTTTGATAATATTAAAT-3'
 
 
 
 
 
 
 
 
Supplementary material 
Suppl.M1: Similarity of Adr sequences in Rickettsia spp. 
The sequences similarity of the putative adhesins Adr1 and Adr2 for all 
sequenced rickettsial species. 
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Suppl.M2: The sheet of Adr2 recombinant protein production 
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Suppl.M3: SDS-PAGE and corresponding Western blot performed 
with mAbs anti-groEL and anti-RP059. 
The recombinant protein (10µg) groEL and RP059 respectively were 
resolved on 10% acrylamide SDS-PAGE. The corresponding Western 
blot was performed with either anti-GroEL or anti-RP059 monoclonal 
antibody at the dilution 1:10. 
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 Article 2 – Preamble 
 
 
 
SFG rickettsiae are obligate intracellular pathogens able to manipulate 
the actin cytoskeleton, thus enabling cell-to-cell spreading during 
infection. The genomic comparison of motile SFG with the non-motile 
TG bacteria allowed  to evidenced that bacteria from the SFG, able to 
form actin comets and  to move in the cytoplasm, encode for a protein 
sharing a domain organization similar to the actin assembly-inducing 
protein  ActA, responsible for actin polymerisation in Listeria species 
(Ogata H et al., 2001). It was later demonstrated that the R. conorii 
RickA can effectively activate Arp2/3 and induce actin polymerization in 
vitro (Gouin et al., 2004, Jeng et al., 2004). The precise molecular 
mechanisms leading to RickA-mediated rickettsia motility were not 
elucidated. First, and based on the lack of peptide signal, its localization 
as a membrane protein was for long questionnable. In addition, and while 
bacterial factors involved in motility are usually polarized, in the case of 
RickA the polarization was not clearly determined (Carlsson and Brown, 
2006, Stevens et al., 2006). 
The aim of this work was thus to carefully analyze the localization of 
RickA, using R. conorii as model. Two approaches were used starting by 
immunofluorescence assays on infected cells. Localization was then 
refined by immunogold coupled to transmission electron microscopy 
analysis.  The results obtained were depicted in the paper presented 
above. 
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INTRODUCTION 
Rickettsiae are bacteria highly specialized for obligate intracellular 
existence in both mammalian cells and arthropod vectors (Raoult and 
Roux, 1997; Winkler, 1990). Historically, they have been classified into 
three groups based on immunological cross-reactivity and vector species: 
“spotted fever group” (SFG) with agents R. conorii, R. rickettsii and R. 
raoultii, the “typhus group” (TG) with R. prowazekii and R. typhi and the 
“scrub thyphus” (STG) (Raoult and Roux, 1997). However, this 
classification is probably simplistic, because some Rickettsia spp. do not 
conserved these criteria of classification (Merhej et al., 2009; Merhej and 
Raoult, 2010). For example, SFG rickettsiae are definied as living in 
ticks, but exceptions include R. akari (transmitted by mites) and R. felis 
(transmitted by cat and dog fleas) (Merhej et al., 2009; Merhej and 
Raoult, 2010). Recently, a “transitional group” including these 2 
rickettsial species (R. felis and R. akarii) has been proposed (Gillespie et 
al., 2007; Gillespie et al., 2010; Merhej et al., 2009). The SFG group 
bacteria, in contrast to TG, have the capacity to move from cell to cell 
and within the cells.  
Exploitation of the host-cell actin cytoskeleton is crucial for several 
microbial pathogens to enter and disseminate within cells, thus avoiding 
the host immune response (Carlsson and Brown, 2006; Stevens et al., 
2006).  
It was proposed that actin in rickettsial tails is nucleated by host Arp2/3 
complex and the bacterial proteins rickA (Balraj et al., 2008a; Gouin et 
al., 2004) and recently discovered Sca2 (Haglund et al., 2010). The 
rickettsial gene rickA of SFG Rickettsiae was identified through a 
comparative analysis of R. conorii and R. prowazekii genome (Ogata et 
al., 2001).  
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It encodes for a 517- amino acid protein rickA (Gouin et al., 2004; Gouin 
et al., 2005) which shares some similarities in its carboxy-terminal region 
with human WASP family proteins able to activate Arp2/3 in vitro 
(Gouin et al., 2004; Jeng et al., 2004). Because genetic manipulations are 
still difficult, the role of rickA in the motility of Rickettsiae has not been 
formerly demonstrated (Balraj et al., 2008b).  
Its function was in part supported by the absence of motility of R. 
peacockii, a strain for which rickA is disrupted by an insertion sequence 
IRSpeI (Simser et al., 2005). RickA activates the Arp2/3 complex in vitro 
and stimulated motility of rickA-coated beads in Xenopus extracts (Gouin 
etal., 2004; Jeng et al., 2004). Therefore, several points remain unclear. 
RickA was found to be expressed on the bacterial surface (Gouin et al., 
1999; Gouin et al., 2004), but the amino-acid sequence of rickA does not 
display any signal sequence or C-terminal motif that could act as a 
membrane anchor (Gouin et al., 2004). The experiences with rickA 
transfected cells designed to drive expression of the protein in the inner 
face of the plasma membrane, showed that rickA is a surface protein 
expressed on R. conorii involved in Arp2/3 activation and inducing actin 
polymerization (Gouin et al., 2004). It has been shown that rickA protein 
was expressed on the surface of R.conorii using immunofluorescence 
(IFA) (Gouin et al., 2004) and in R. raoultii by using monoclonal 
antibody through western blot (Balraj et al., 2008c).  
However, it is unknown how rickA is addressed to the bacterial surface 
and whether the type IV secretion system predicted by the genome 
sequence is involved in targeting to the surface (Gouin et al., 2004) 
(Figure 1). Indeed, the ultrastructural studies of fine structure of 
Rickettsiae by using electron microscopy were conducted in late 1980thies 
(Hase, 1985; Silverman et al., 1974; Silverman et al., 1978; Silverman, 
1991; Silverman and Wisseman, Jr., 1978) and aimed to compare the 
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physical conformation of the outer envelope of Ricketsiae by electron 
microscopy, revealed some differences within Rickettsiae from TG and 
SFG when compare to O. tsutsugamushi (Silverman et al., 
1978;Silverman and Wisseman, Jr., 1978). The TG and SFG Rickettsiae 
shared together with E. coli very similar configuration of the outer 
envelopes (Figure 2) (Silverman and Wisseman, Jr., 1978). However, 
together with O. tsutsugamushi, the SFG Rickettsiae possess additionally 
to “microcarpuscular layer”, the slime layer, external to the cell wall 
which is probably the locus of major group-specific antigens (Silverman 
et al., 1978). Based on the model of R. conorii surface expressed protein 
(Gouin et al., 2004), the aim of the present study was to demonstrate the 
surface localization of rickA protein in the R. conorii by using combined 
approaches: immunofluoresce assay using anti-rickA monoclonal 
antibody (Balraj et al., 2008c) and TEM analysis through immunogold 
labeling. 
 
MATERIALS AND METHODS 
Eukaryotic cell lines and bacterial strains 
R. conorii strain seven were propagated within murine fibroblast 
monolayers, L929 cell line (ATCC CCL 1) or African green monkey 
kidney cells (Vero cell, ATCC C1587) in Eagles minimum essential 
medium (MEM, Gibco, Invirtogen, Paisley, UK) supplemented with 4% 
foetal calf serum (FCS, Gibco) and 1% L-glutamine (Gibco) in 150 cm2 
tissue culture flasks at 32ºC as described (Balraj et al., 2008b). The 
rickettsiae were harvested when the Vero cells were engorged by bacteria 
(3 to 7 days), which corresponded to exponential phase of growth. 
Supernatant of infected rickettsial cell culture, containing rickettsiae and 
detached host cells, were collected and centrifuged at 200 x g for 10 min 
to eliminate cells and free rickettsiae were pelleted by 8000 x g for 10 
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min. This bacterial sample was used to prepare immunofluorescence 
assay (IFA) slides. Bacterial growth was monitored by Gimenez staining 
(Gimenez, 1964). Additionally, the quantification of bacterial DNA has 
been performed as internal control of replication. The standard curve used 
in routine diagnostic was applied for DNA quantification at the same 
sampling times as for monitoring by Gimenez staining. The specific 
primers to detect genomic DNA from R. conorii were used, coding for 
putative acetyltransferase F: 5’-TTG-GTAGGC- AAG-TAG-CTA-AGC-
AAA-3’ and R: 5’-GGAAGT- ATA-TGG-GAA-TGC-TTT-GAA-3’, 
sondeFAM-GCG-GTT-ATT-CCT-GAA-AAT-AAG-CCGGCA TAMRA 
(Bechah Y et al., 2011;Bechah et al., 2007). 
 
Immunofluorescence assay 
Anti-RickA monoclonal antibody was previously described (Balraj et al., 
2008c). Bacterial suspension was spotted on 18well slides using pin head 
nib and slides were air dried and fixed with 100% methanol for five 
minutes at room temperature (RT). Slides were incubated for 30 minutes 
at RT in humidified condition with mouse monoclonal anti-rickA 
antibody (1:100) diluted in PBS-Tween (0.1%) with bovine serum 
albumin (BSA 3%, Euromedex, France).  
After two times PBS-Tween (0.5%, 5 min each) washes, bound antibody 
were probed with antimouse IgG conjugated biotin (1:1000; Beckman 
Coulter Company, France) diluted in PBS-Tween (0.1%) with BSA (3%) 
for 30 minutes at RT. Further washing was performed in PBS-Tween 
(0.5%, 5 min each) for two times. Then slides were incubated with 
streptavidin conjugated to fluorescein isothiocyanate (1:500; Bioscience 
BD pharmingen, France) for 30 minutes at RT. After two washes with 
PBS-Tween (0.5%, 5 min each) slides were air-dried and cover slips were 
mounted on slides with DAPI (4, 6- diamidino-2- phenylindole, Prolong 
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Gold Antifade Reagent. Molecular Probes) from a ready to use solution 
and examined under an olympus BX-51 epifluorescence microscopy at X 
100 magnification for image analysis. A naive mouse serum was used for 
negative control. Table 1 summarized the controls that were used in this 
study. 
 
Transmission electron microscopy 
Transmission electron microscopy (TEM) analysis was conducted on 
L929 cells infected with R. conorii. A 125 cm2 flask infected with 
R.conorii for 96 h was carefully collected and pelleted by centrifugation 
before fixation in 2% glutaraldehyde (Electron Microscopy Sciences, 
Hatfield, PA, USA) and cacodylate buffer (0.1 M) overnight at 4°C. After 
washing with cacodylate buffer (0.1M), the samples were further fixed 
for 1 h at room temperature with 2% osmium tetroxide (0.1M), 
dehydrated in an ascending series of ethanol (30% to 100%) and 
embedded in Epon 812 resin (Electron Microscopy Sciences). Ultrathin 
sections (70 nm) were transferred on 300 mesh nickel Formvar/carbon 
grid (TAAB Laboratories, England).  
The grids were pre-treated twice with 50 mM NH4Cl in PBS (5min 
each). After washing with PBS for four times (5 min each), the grid were 
pre-incubated with solving solution I (PBS, BSA (1%), normal goat 
serum 1% (NGS, DAKO, Denmark), Tween20 (0.2%) for two times (5 
min each) in 2% osmium tetroxide (0.1M). The grids were incubated 
1h30 with monoclonal mouse anti-rickA antibodies (1:50) diluted in 
solving solution I. After washing 4 times (10 min each) with solving 
solution I, grids were incubated 90 mins with anti-mouse IgG biotinyled 
antibody (1:100, Beckman Coulter Company, France) diluted in solving 
solution I. Following gentle washing with BSA (0.1%) in PBS for two 
times (5 min each), the grids were pre-incubated two times (5 min each) 
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with solving solution II (PBS, Fish skin gelatine (0.01%), Aurion 
Immuno Gold Reagents & Accessories, Netherlands). The grids were 
incubated for 1h30 min with streptavidine (1:40) gold 10 nm conjugate 
reagent (Aurion Immuno Gold Reagents & Accessories, Netherlands), 
diluted in solving solution II. The specimens are washed with incubation 
solution II for two times (5 min each).  
Finally, the grids were washed in distilled water for 2 times (10 min each) 
and stained with uranyl acetate (3%, Prolabo, France) in water. Then, 
grids were allowed to dry at room temperature before examined on a 
Philips Morgagni 268D electron microscope (FEI Company, Limcil-
Brevannes, France). A negative control was carried out by using serum of 
naïve mice. 
 
Statistical analysis 
One hundred individual fields were taken and gold particles were counted 
for inner membrane (IM), outer membrane (OM) and space around 
rickettsia (ECS). We have performed one-tailed paired t-test (Graphpad 
Prism software). The graphs were also compiled in this software. 
 
RESULTS 
Detection and localisation of rickA in R. conorii 
As illustrated in figure 3A, fluorescence labelling of rickA was amplified 
using biotin-streptavidin conjugate and showed that the protein was 
expressed on the surface of R. conorii. In all negative controls (Table 1) 
there was no fluorescence intensity over the bacterial surface (Figure 3B). 
The distribution of RickA in R. conorii is shown in figure 4.  
The number of gold particles present within inner membrane (IM) and 
outer membrane (OM) were less when compared with the number of gold 
particles present outside of rickettsiae (ECS) but not statistically 
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significant. The ECS corresponds to the zone which is found outside of 
rickettsial organism sampled from supernatant of R. conorii culture. 
However, we found that the most significant difference (p=0.0024) was 
observed between the number of gold particles localized on IM and OM. 
The significant t-test (p=0.0316) was also observed for number of gold 
particles localized on OM in comparison with those of ECS. However, no 
significant difference was observed if we compare the number of gold 
particles localized on IM of the cell in comparison with those of ECS 
(p=0.2747). 
 
DISCUSSION 
The present study showed the surface expression of rickA in R. conorii 
using anti-rickA specific monoclonal antibody in IFA (Figure 3A). Our 
results skewed with the work of Gouin et al. who demonstrated that rickA 
is localized at the surface of the bacteria using IFA evidenced where actin 
polymerization occurs (Gouin et al., 2004). We can hypothesize that 
rickA found in ECS may be indirectly involved as a nucleation-promoting 
factor (NPS) which mediates actin nucleation (Figure 1). Actin is one of 
the most abundant proteins in eukaryotic cells and exists in two forms, 
ATP-bound monomeric (G) actin and ADP-bound filamentous (F) actin 
(Stevens et al., 2006). Polymerization of actin requires ATP hydrolysis 
and it is tightly regulated by monomer- and filament- binding proteins 
that also maintain the free monomer pool and mediate capping, cross 
linking, bundling or severing of actin filaments (Stevens et al., 2006).  
An initial nucleation step creates free barbed ends by uncapping or 
severing of filaments or de novo nucleation of monomers (Stevens et al., 
2006). This step is stimulated by cellular factors, as complex Arp2/3, 
which in turn, are activated by proteins known as NPFs such as Wiskott-
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Aldrich syndrome proteins (WASP family proteins) (Figure 1). In the L. 
monocytogenes model, the conformational changes of Arp2/3 complex 
induced by NPFs might allow these subunits to mimic barbed ends to 
serve as template for polymerization (Stevens et al., 2006). Surprisingly, 
Serio et al. did not identify a cellular actin nucleator (Arp2/3 complexe) 
in R. parkeri, suggesting that it is not required for actin-based rickettsial 
motility (Serio et al., 2010).  
Therefore, in the case of Rickettsiae, the molecular mechanism of actin 
assembly and organization, as well as the exact role of nucleation 
activators like rickA and sca2, is still obscure (Balraj et al., 2008a;Gouin 
et al., 2004; Haglund et al., 2010;Kleba et al., 2010; Serio et al., 2010). 
Both well conserved genes among SFG rickettsiae: R. conorii rickA 
(Gouin et al., 2004) and R. rickettsi sca2, a member of a family of large 
autotransporter proteins (Kleba et al., 2010), were reported to be required 
for motility and virulence. Indeed, when Sca2 was truncated by 
transposon insertion, the Sca2 mutant bacteria do not generate actin 
comet tails (Kleba et al., 2010). Probably, the sca2 N-terminus which is 
structural homolog of formin homology 2 domain, is involved in 
nucleation of unbranched actin filaments, processively associated with 
growing barbed ends, requires profiling for efficient elongation, and 
inhibits the activity of capping protein (Haglund et al., 2010). RickA 
includes proline-rich regions sharing the homology with WASP proteins 
and is considered as NPF. The surface localization of the rickA protein 
might allow its secretion and acting as NPF involved in actin 
polymerization. However, the contribution of rickA protein in this process 
has not been completely elucidated.  
Many questions remain unanswered: the mechanism of rickA secretion 
how is rickA targeted to the surface of host cell, as well as identification 
of other NPFs and the role of T4S (Figure 1). With respect to recent data, 
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the mechanism of actin-based motility is still under study and the 
rickettsial as well as host cell factors involved in this process remain to be 
determined. The recent work of Serio et al. (Serio et al., 2010) showed 
that numerous host cell proteins are involved in R. parkeri infection and 
actin-based motility (profiling, fimbrin/T-plastin, capping protein and 
ADF/cofilin) (Serio et al., 2010).  
Interestingly, Fimbrin/T-plastin and profiling are required for R. parkeri 
motility, but they are not indispensable for L. monocytogenes and S. 
flexenerii motility (Serio et al., 2010). The bacterial motility depends on 
bacterial species and can differ among SFG different strains and species. 
In this report we address only the question of rickA protein localization in 
R. conorii bacterium (Figure 1). IFA is commonly used technique to 
monitor the global expression of bacterial proteins. However, this 
technique is frequently performed in combination with other modern 
approaches which yielded better image resolution. Indeed, TEM enables 
the study of small details in the cell down to near atomic levels.  
The possibility for high magnifications has made the TEM a valuable tool 
in both medical and biological research (Robinson, 1986). TEM has been 
successfully applied to determine the subcellular localization of bacterial 
protein Hfq (Diestra et al., 2009) and the extracellular site evidence of 
virulent plasmid pYV harbored by Yersinia pseudotuberculosis (Simonet 
et al., 1990), as well as expression of IcsA and ActA on the surface of 
Shigella flexneri (Nhieu and Sansonetti, 1999), Listeria monocytogenes 
(Cossart and Kocks, 1994) and surface expression of rickA in R. raoultii 
(Balraj et al., 2008c). However, by using TEM, we demonstrated that 
RickA is widespread in R. conorii (Figures 4 and 5). It has been shown 
that other bacterial components like IcsA, ActA, or BimA are known to 
be responsible for intracellular motility and exhibit a polarized 
distribution (Goldberg and Theriot, 1995; Kocks et al., 1993; Stevens et 
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al., 2006). Such polarization was not observed for rickA which was found 
to be expressed over the entire bacterial surface in R. conorii in the study 
of Gouin et al. (Gouin et al., 2004) as in our study (Figures 3 and 4). 
Thus, our results skewed with the results of this group (Gouin et al., 
2004). 
 
CONCLUSION 
In conclusion, we have shown the global expression of rickA in R. conorii 
cell by using IFA approach (Figure 3). The results of TEM showed that 
gold particles were distributed over the entire surface of R. conorii. This 
result emphasizes the importance of disclosing the detailed mechanism of 
rickA secretion and it’s targeting to the host cell surface, and to determine 
the host receptors and factors involved in the dynamics of actin-tail 
formation and its motility inside the cell. For future prospects it will be 
suitable to fractionate the different bacterial compartments and to 
demonstrate the presence or absence of rickA in each compartment. 
Localization of proteins in cells has largely relied upon the use of specific 
antibodies. The results presented here show that anti-rickA monoclonal 
antibodies provided the same labeling pattern over almost the entire 
bacterial surface. 
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Table 1. The controls included in IFA experiments 
  +/- indicates whether the antibody added or not. 
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Figure 1  
Summary of rickA protein roles in rickettsial physiopathology  
rickA is involved in actin polymerization (transformation of monomeric 
actin G to filamentous actin F). An initial nucleation step creates free 
barbed ends by uncapping or severing of filaments or de novo nucleation 
of monomers. The complex of actin- relating protein (Arp) 2/3 involved 
in actin nucleation seems to be activated by nucleation-promoting factors 
(NPFs) as WASP proteins and rickA. However, the mechanism of actin 
polymerization in the model of Rickettsiae has not been completely 
elucidated. Several questions remain without response (grey boxes): (i) 
rickA protein secretion, (ii) how the Arp2/3 complex of actine is activated 
by rickA, (iii) There are other bacterial cofactors involved in actin 
polymerization, (iv) Is the T4S is involved in targeting rickA to the cell 
surface? (v) Is T4S is involved in host genes regulation? (vi) How 
Rickettsiae spread in the cell and from cell to cell? The question which is 
the object of this study concerns the rickA localization in R. conorii cell. 
To respond to this question, IFA and TEM were performed.  
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Figure 2  
 
A) Schema of the cell membrane and B) Model of rickettsial surface 
membrane assembly. a) Schematic model of TG and SFG Rickettsiae of 
the cell membrane, outer envelope (cell wall) and adjacent extracellular 
layers. Rickettsiae are characterized by a specific membrane structure. 
The outer envelopes of SFG Rickettsiae are as follows: 1)An outer leaflet 
(OM) with additional “microcorpuscular layer” (ML) and ended with 
external slime layer (SL), 2) The peptidoglycan layer (PS) is localized 
between the OM of the cytoplasmic membrane (CM) and the inner leaflet 
(IM) of the cell wall; (Adapted from Silverman et al., (Silverman and 
Wisseman, Jr., 1978) b) Surface membrane assembly of Rickettsiae. In 
the rickettsial assembly, the rickettsial body formed first, and the 
rickettsial envelope subsequently formed over the body (Hase, 1983). The 
previously proposed mechanism of rickettsiae assembly is as follow: 1. 
The body of nascent Rickettsia took a definitive form, a fuzzy material 
mainly composed of lipoproteins is formed over the body, and graduatly 
separate the emerging rickettsia from the surrounding cytoplasm. 2. The 
assembly of the rickettsial limiting membrane on the ricketsial surface 
along the fuzzy zone occurs in close association with ribosomes. 3. The 
surface ribosomes are associated with rickettsial plasma membrane, 
although the plasma membrane of the assembling rickettsia is difficult to 
recognize. 4. The short projections of membrane extended from the 
surface ribosomes into the fuzzy zone, and as rickettsial double 
membrane assembled, these projections of membrane, form the septa of 
membranewhich stay connected with the surface of ribosomes and the 
outer membrane (OM) across the periplasmic space (PS).  (Adapted from 
(Hase, 1985) and the image of ribosome has been freely available on 
internet:http://biology.kenyon.edu/courses/biol114/Chap05/RNA_riboso
mes.gif) 
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Figure 3 
Detection of surface expression of rickA protein by indirect 
immunofluorescence  
3A. Detection of RickA expression by IFA. Host cell-free R. conorii was 
fixed in methanol, incubated with rickA anti-mouse monoclonal antibody 
(1:100) followed by an anti-mouse biotin (1:1000), stained with 
streptavidin FITC (1:500) and visualized by epifluorescence microscopy 
(magnifications 100X), showed that rickA was expressed at the surface of 
R. conorii. 3B. the right panel corresponds to negative control. 
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Figure 4 
Localization of rickA (TEM) 
4A. TEM analysis performed on R. conorii cultured on L929 cells using 
rickA anti-mouse monoclonal antibody followed by biotin and with 
streptavidin gold (10 nm); the arrows indicates the distribution of rickA in 
R.conorii cells inner membrane (IM), outer membrane (OM) and 
extracellular space around rickettsies (ECS). 4B. Negative control 
performed using serum of naive mice.  
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Figure 5 
Histograms showing the distribution of gold particles in R. conorii   
Gold particles were counted for one hundred individual fields. The gold 
particles were localized in inner membrane (IM), outer membrane (OM) 
and extracellular space around rickettsies (ECS). A graph was plotted by 
using graphpad prism software.   
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Article 3 – Preamble 
 
 
While serology is the most used diagnostic method for rickettsial 
infections, the lack of specificity and sensitivity remain a major drawback 
(La scola and Raoult, 1997). Cross-reactions probably result from 
antigenically similar epitopes, but the possibility of co-infections can not 
be excluded. Many studies have reported great interest in using 
recombinant proteins rather than purified bacteria in immunodiagnosis. 
The aim of the present work was to propose an efficient diagnostic test, 
based on recombinant proteins, for the detection of R. prowazekii and R. 
rickettsii. To realize our purpose, 45 and 48 target genes of R. prowazekii 
and R. rickettsii were selected for recombinant expression using Gateway 
technology. The choice of targets was not arbitrary, but resulted from the 
large expertise of our laboratory in the field of rickettsiae. Twenty of the 
recombinant proteins obtained were screened by ELISA with sera of 
rickettsioses patients. Results obtained demonstrated a satisfactory 
performance allowing to select discriminating markers of R. typhi and R. 
conorii infection, respectively which may be useful for detection of 
rickettsiae in clinical samples.  
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ABSTRACT 
Rickettsia is Gram-negative obligate intracellular bacteria that cause 
arthropod-borne diseases of humans, including typhus (R. typhi and R. 
prowazekii) and spotted fevers (R. conorii, R. rickettsii). Diagnosis of 
rickettsioses is usually based on diverse serological testing of patient 
serum. The diagnostic antigen used for indirect immunoflorescence assay 
(IFA) considered as the reference method is done with whole purified 
bacteria. Deficiencies of this antigen include (i) potential of 
crossreactivity within different rickettsial species, as well as with other 
pathogens, (ii) the difficulty to obtain sufficient amount of antigen due to 
the requirement for highly specialized laboratory platform in intracellular 
bacteria culture; (iii) finally, discriminate diagnosis of rickettsioses is still 
a great challenge, considering the fact that clinical picture is most often 
not specific. There is therefore a need for serodiagnostic tests 
improvements, especially for a test able to make discrimination between 
Rickettsia from typhus group (TG) from Rickettsia of spotted fever group 
(SFG). In this aim, we have cloned and expressed several proteins of R. 
prowazekii and R. rickettsii using GATEWAY approach. Then, 20 
recombinant protein targets were screened with sera of patients with 
rickettsioses by ELISA. We have identified several potential markers 
which allowed discriminating infection due to R. typhi with those caused 
by R. conorii. These antigens may be useful for the detection of 
Rickettsiae in clinical samples. 
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INTRODUCTION 
Members of the genera Rickettsia are fastidious bacterial organisms that 
are obligate intracellular parasites that reside in the cytosol of the host 
cells and in an arthropod host (La & Raoult, 1997; Socolovschi, 
Mediannikov, Raoult, & Parola, 2009). Rickettsiae have undergone 
evolutionary genome reduction as results of the loss of functions that are 
provided by the host, i.e., genes encoding metabolic enzymes.  
There are four Rickettsia species that frequently cause incapacitating, life 
threatening illness: Rickettsia prowazekii, R. rickettsii, R. conorii, and R. 
typhi. 
Actually, the clinical manifestations of most rickettsioses are 
characterized by a continuous spectrum gaped by appearance of some 
worldwide reemerging cases. However, some examples showed  
inconsistent clinical manifestations hardly correlated with geographical 
context, which makes clinical diagnosis uncertain. To date, laboratory 
diagnosis of rickettsioses is based on various PCR assays, DNA 
sequencing which allows convenient and rapid identification of 
rickettsiae, even in non referenced laboratories (La Scola& Raoult, 1997). 
However, the diagnosis of rickettsial illness is confirmed by serological 
testing (La Scola& Raoult, 1997). Several conventional methods were 
used in serology: historic Weil-Felix test (Weil & Felix, 1916; Eremeeva, 
Balayeva, & Raoult, 1994), the complement-fixation test (Shepard, 
Redus, Tzianabos, & Warfield, 1976), the microagglutination test (Fiset, 
Ormsbee, Silberman, Peacock, & Spielman, 1969) and the indirect 
hemagglutination test detects antibodies to an antigenic erythrocyte-
sensitizing substance (Anacker, Philip, Thomas, & Casper, 1979). Lately, 
these methods became obsolete and were replaced in the early 1980th 20 
by others easier to handle and guaranteed better sensitivity and 
specificity: (i) ELISA, first introduced for detection of antibodies against 
 98
R. typhi and R. prowazekii (Halle, Dasch, & Weiss, 1977) considered as 
highly sensitive and reproducible, allowing the differentiation of IgG and 
IgM, then extended to diagnosis of RMSF (Clements et al., 1983) and 
scrub typhus (Dasch, Halle, & Bourgeois, 1979; Crum, Hanchalay, & 
Eamsila, 1980), (ii) IFA in format of micromethod which is to date, 
considered as reference test (Philip, Casper, Ormsbee, Peacock, & 
Burgdorfer, 1976). The advantage of micro-IFA is the simultaneous 
detection of several antibodies to a number of rickettsial antigens in a 
single well with the same drop of patient serum. It allows isotyping of Ig: 
IgG, IgM and IgA which with detection of IgM provides a strong 
evidence of recent active infection, although the diagnosis may be  
compromised. Western blot and antigen adsorption has been also used in 
routine and is considered as powerful serodiagnostic tool for 
seroepidemiology, especially applied for doubtful cases and allows 
confirmation of serologic diagnosis obtained by conventional methods 
(Sompolinsky et al., 1986; Raoult & Dasch, 1989b; Raoult & Dasch, 
1989a; Raoult & Dasch, 1995). The drawback of ELISA, IFA and 
adsorbed western blot in routine, is that they require the laboratory 
platforms specialized in culturing of Rickettsiae and in antigen 
purification. However, the serologic evidence of infection occurs no 
earlier than the second week of illness for any of rickettsial diseases (La 
Scola& Raoult, 1997). In practical, several diagnostic methods are used 
for Rickettsiae detection. In the specialized laboratories, molecular 
biology, serodiagnostic with IFA and adsorbed western blot and shell vial 
 culture are used systematically. Because it is difficult to diagnose 
rickettsial infection early after infection occurs, administration of 
antibiotic treatment before a definitive diagnosis is made (Pelletier & La, 
2010). Preventive measures are complicated because of the lack of 
effective and safe rickettsial vaccines (Walker, 2007). To detect 
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efficiently bacteria in clinical samples, we need to dispose of highly 
sensitive, specific and available detection tests.  
The aim of the present work was to propose an efficient diagnostic test 
based on recombinant proteins for detection of R. prowazekii and R. 
rickettsii. To realize our purpose, first we have selected for in vivo 
expression 45 and 48 genes targets of R. prowazekii and R. rickettsii, 
respectively. From this selection, we have successfully attempt to express 
about 50% of targets using Gateway technology (Vincentelli R et al., 
2011). Finally, we have screened 20 of all these recombinant proteins by 
ELISA and selected discriminate markers of R. typhi and R. conorii 
infection, respectively which may be useful for detection of Rickettsiae in 
clinical samples. 
 
MATERIAL  & METHODS 
2.1) Choice of protein targets for cloning and expression 
  The choice of protein targets was defined according to previous studies 
showing an important role of rickettsial proteins which can be detected by 
human antibodies (Renesto et al., 2005; Renesto et al., 2006), as well as, 
proteins involved in physiopathological processes: RickA (Balraj et al., 
2008; Balraj, Nappez, Raoult, & Renesto, 2008), rOMPB, rOMPA, adr2 
(Renesto et al., 2006) which therefore offer opportunities for their 
application in medical diagnosis/vaccine and subsequent studies  
(Table1). This list of genes to be cloned was subsequently enlarged for R. 
prowazekii and R. rickettsii because of the low success rate. Indeed, in the 
first series of targets (13 target for R. prowazekii and 12 targets for R. 
rickettsii) to be cloned, respectively 6 and 3 clones have been obtained for 
these pathogens (SM1) (Vincentelli R et al., 2011). Since the cloning and 
protein expression of intracellular bacteria such as Rickettsiae cause 
problems in case of membrane proteins, insoluble and soluble form etc, 
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so we decided to select the majority of soluble target (SM1). The nucleic 
acid sequences of ORFs were extracted from genomic library (NCBI). 
The predicted signal peptide (http://bp.nuap.nagoya u.ac.jp / sosui / 
sosuisignal / SOSUIsignalDB /) sequence was removed. 
 
2.2) Construction and identification of recombinant expression 
plasmids  
DNA of R. prowazeki strain Madrid E and R. rickettsii strain Sheila Smith 
was extracted using commercially available kit (Qiagen, Chatsworth, CA) 
according to manufacturer’s instructions. Twenty targets were 
subsequently PCR amplified (Expand High Fidelity PCR System, Roche 
Diagnostics, Meylan, France) using specific primers containing at their 5’ 
and 3’ ends the respective attB1 and attB2 recombination sites. Each 
purified PCR product was transferred according to manufacturer’s 
instructions (Gateway Cloning Technology/Invitrogen Life Technologies) 
in a first recombination step (BP) into the pDONR201 vector to generate 
an entry clone used in a second recombination step (LR) with the 
destination Gateway vector pETG-20A to generate expression clones 
contain an N-His6 tag plus a fusion protein thioredoxin (TRX) (Canaan et 
al., 2004; Vincentelli R et al., 2011) that enhances expression of the 
fusion partner (Vincentelli et al., 2003; Vincentelli, Canaan, Offant, 
Cambillau, & Bignon, 2005; Vincentelli R et al., 2011). The resulting 
entry and expression clones were transformed into E. coli DH5α cells, 
and constructions were confirmed by DNA sequencing and PCR 
screening, respectively.  
 
2. 4) Expression and purification of recombinant proteins  
All steps of expression and purifications were performed as previously 
described (Sekeyova et al., 2010; Vincentelli R et al., 2011). Briefly, 
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expression vectors carrying the 20 targets were transformed into E. coli 
strain Rosetta (DE3) pLysS (Novagen). The growth conditions, induction 
and harvest was done as previously described (Vincentelli R et al., 2011). 
The bacterial pellet was resuspended in lysis buffer (50mM Tris-HCl pH 
8.0, 300mM NaCl, 0.1% Triton X-100, 1mM ethylenediaminetetraacetic 
acid [EDTA], 0.25 mg/ml lysozyme and 1mM phenylmethylsulphonyl 
fluoride [PMSF]) and frozen - 80°C for at least 1 hour. After thawing the 
bacterial pellets and the addition of DNAse I (2µg/ml) and MgSO4 (20 
mM) the lysed cells were centrifuged to separate the soluble fraction from 
the bacterial debris. The pellet was used for subsequent steps of 
purification. The proteins were purified by affinity chromatography based 
on the affinity of the Histidine tag (HHHHHH) with Nickel ions. The 
pellet fraction of the lysate was solubilised in buffer A (50mM Tris-HCl, 
300mM NaCl, 250mM Imidiazole pH 8.0) containing 8M GnHCl and 
centrifuged to separate the supernatant containing the recombinant 
proteins and pellet with the cellular debris. The solubilzed proteins were 
loaded on a Nickel affinity chromatography Histrap (GE Healthcare) and 
eluted in denaturant condition in the buffer B (buffer A + 6M urea, 
imidazole 250mM, pH 8.0). The fractions containing proteins were 
pooled and stored in 50% glycerol at -20°C. Total expression was 
visualized by SDS-PAGE according to standard protocols (Cleveland, 
Fischer, Kirschner, & Laemmli, 1977; Towbin, Staehelin, & Gordon, 
1992). The identity of recombinant protein was confirmed by mass 
spectrometry. 
 
2.5) ELISA 
Modified ELISA assay was performed as previously described (Sekeyova 
et al., 2010). Briefly, 96 well plates (immunolon4, vwr) were coated 
overnight at +4°C with purified recombinant protein (10 µg/ml, 100µl per 
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well) diluted in carbonate-bicarbonate buffer (15mM Na2CO3, 35mM 
NaHCO3, pH 9.6). The following steps were performed according to 
standard protocols (Sekeyova et al., 2010). The human sera were diluted 
1/1000 in PBST-milk. Alkaline phosphatase-conjugated goat anti-human 
IgG (whole molecule) (Sigma) (1/5000), alkaline phosphatase yellow 
para-nitro-phenyl phosphate (pNPP) (Sigma) were used as described 
(Sekeyova et al., 2010). The reaction was read with a microplate reader 
(Multiskan EX, Labsystems, Thermo Fisher Scientific, Waltham, MA) at 
a wavelength of 405 nm and data analysed by GraphPad Prism (San 
Diego, CA). A positive control consisted in positive serum with active R. 
typhi and R. conorii infection; a negative control consisted in negative 
serum. Each serum sample was tested at least in duplicate. The cut-off 
was determined as described (Sekeyova et al., 2010). Any samples 
exhibiting absorbance above the cut off value was considered as positive 
(Figure 1A&B). 
 
2.6) Human sera  
In this study, 10 patients sera (group R. typhi) with an infection due to R. 
typhi and 28 sera the patients diagnosed for active R. conorii (group R. 
conorii) infection diagnosed at the Unité des Rickettsies 
(Marseille, France) were included in this study after giving informed 
consent (Table2). The diagnosis was based on serology and PCR assays 
targeting (Socolovschi et al., 2009). A control group (group HBD) 
consists in 10 healthy blood donors. 
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3) RESULTS AND DISCUSSION 
Here, we describe the tools for detection of Rickettsiae in clinical samples 
using recombinant rickettsial proteins. In this aim, we produced 20 and 
23 recombinant proteins of R. prowazekii and R. rickettsii with 20 which 
we used for ELISA. Finally, we screen them for the best 
serodiagnosticmarkers for R. typhi and R. conorii discriminate 
serodiagnosis.  
 
Selection of genes targets for protein expression 
 Initially, 12 and 13 protein targets have been selected for cloning and 
expression of R. prowazekii and R. rickettsii, respectively (Table 1, SM1). 
However, the success rate of cloning and expression was very low (46% 
and 25%, respectively). Rickettsiae are obligatly intracellular bacteria, 
their genetic manipulation is strongly limited in these conditions 
(Renesto, Ogata, Audic, Claverie, & Raoult, 2005). The first attention 
was to choose the genes described as immunogenic for patient’s or 
immunized animal’s sera (Table 1, SM1). Consequently, the list of targets 
was enlarged taking care to remove highly hydrophobe-, membrane 
proteins of high MW known to be difficult to manipulate. This choice 
was determined by technical limitations and it is controversial when 
considering that the majority of immunogenic proteins are surface 
proteins, described as sca family proteins within rickettsial species, i.e., 
rOmpB ubiquitous in all Rickettsiae and rOmpA presents only in SFG 
group. 
Indeed, the genes sca5 (rOmpB) and rOmpA are also used in diagnosis by 
PCR (Parola, Paddock, & Raoult, 2005). They are the most reacting 
proteins in adsorbed western blot. This study opened the opportunity to 
screen for diagnostic usage other not yet known in clinics the protein 
targets (SM1). In the context of growing interest of synthetic gene 
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synthesis, optimization of sequence for codon usage which has been 
identified as the single most important factor in prokaryotic gene 
expression (Lithwick & Margalit, 2003). Therefore, the improved E. coli 
strain for codon usage (Rosetta BL21 pLysS) was used. However, an 
analysis of codon usage remains to be performed. Most frequently, the 
problems of protein expression occur after cloning showing mutation or 
another unknown phenomenon (Vincentelli et al., 2005). A low yield of 
expression may probably be due to their cellular toxicity or another of 
numbered parameters required for successful protein expression.  
 
ELISA a diagnostic tool for detection of rickettsioses  
Two species of the typhus group, R.typhi and R.prowazekii, are 
pathogenic for human beings. R. typhi causes murine typhus (MT), a flea-
transmitted disease that occurs in warm climates (Bechah, Capo, Mege, & 
Raoult, 2008). R. prowazekii is responsible for epidemic typhus (ET), a 
disease of cold months when poor sanitary conditions are conductive to 
lice proliferation (Bechah et al., 2008). ET was thought to be a sporadic 
disease (Bechah et al., 2008), but now is considered as a re-emerging due 
to its increasing prevalence during political conflicts associated with large 
human migration i.e. camps of refugees associated with breakdown of 
social conditions (Gillespie, Ammerman, Beier-Sexton, Sobral, & Azad, 
2009) and variation in ecology of rat-flea cycle of R. typhi infection in 
North and Central America, involves commensal rats, opossum, cat flea 
(Gillespie et al., 2009). Outbreaks of MT were reported in Africa, 
Australia, Thailand, China, Kuweit, Spain and Portugal, but it remains 
often unrecognized in Africa (Mouffok, Parola, & Raoult, 2008) and in 
South-West Asia (Niang et al., 1998; Watt & Parola, 2003). The cohort of 
patients infected by R. typhi in the present study is only n=10. 
Considering infection due to R. typhi as sporadic in Europe (Bechah et 
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al., 2008), our cohort represents 1 year collection of patients diagnosed in 
Rickettsial Diagnosis Reference Unit, Marseille, France. Almost all of 
our patients are imported MT from a travel from endemic zones (Parola, 
Davoust, & Raoult, 2005; Bitam et al., 2009). Even if prevalence of MT 
is worldwide, remains under diagnosed because of unspecific clinical 
symptoms. Not all (<50% of cases) of patients from our study presents 
rash (Table 2) considered as hallmark of rickettsial diseases often 
transient or difficult to observe. Athralgia, myalgia, or respiratory and 
gastrointestinal symptoms, as well as, neurologic signs may also occur. 
Thus, the clinical picture of MT can be confounded with other diseases 
(Azad, 1990). Moreover, the clinical features, such as fever, rash, 
regional lymphoadenopathy are commonly present in tick-borne 
rickettsioses, i.e. MSF caused in the Mediterranean area and Europe by 
R.conorii. The main clinical difference between MT and MSF is presence 
of coetaneous eschar following the tick bite in R. conorii infected 
patients. However, in the absence of eschar, the clinics of both, MT and 
MSF can be easily confounded. Serologic tests are the most frequently 
used and widely available methods for diagnosis of rickettsioses (La & 
Raoult, 1997; Shepard et al., 1976). However, the cross reactions 
between the different rickettsial species make discrimination difficult. 
Adsorbed western-blot is very helpful in diagnosis (SM2). In the present 
study, the results of western blot were decisive in establishment of 
diagnosis and were performed for the majority of patients diagnosed in 
our laboratory. When the non adsorbed WB doesn’t allow concluding, 
then adsorbed WB is performed (SM2). In some cases, WB performed on 
absorbed serum (SM2 (F, H)) hardly contributes to diagnosis. Finally 
diagnosis is based on clinics and several diagnostic tests. To facilitate the 
discrimination between R. typhi and R. conorii patients, we screened in 
this aim 20 recombinant proteins (10 of R. prowazekii (group typhus) and 
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10 of R. rickettsii (group MSF)). Four recombinant proteins were found 
to cross-react with both, sera infected with R. typhi and R. conorii (Table 
3). This result is not surprising because they belong to well conserved 
bacterial proteins: groEL, Adr2, murC and EF-Tu (Table 3). Adr2 is 
ubiquitously presents within Rickettsiae and acts as one of putative ligand 
recognized by host cell surface proteins. Rickettsial entry into the host 
cell is mediated by the rOmpB protein, which attaches to the host cell 
receptor Ku70, a component of the DNA-dependent protein kinase 
(Uchiyama, Kawano, & Kusuhara, 2006; Uchiyama et al., 2006). Several 
tested in this format recombinant protein were discriminate for diagnosis 
of infection due to R. typhi, despite their origin: targets from R. 
prowazekii (RP016, groEL, RP173), as well as, targets from R. rickettsii 
(PLD, Sca10, EF-Tu, A1G_00215) supporting already documented the 
cross-reactivity among Rickettsia species. Interestingly, among these 
targets we found Sca10 protein belonging to a large family of outer 
membrane proteins known as the surface cell antigen (Sca) family 
proteins and PLD involved in rickettsial adherence and invasion of Vero 
cells. However, these results may be underestimated considered a small 
cohort of R. typhi infected patients. Thus, it will be suitable to validate 
these diagnostic targets on larger study population. None individual 
protein could be enough discriminate for diagnosis of SFG, except three 
targets already used for diagnosis of both, MT and MSF: groEL, adr2 and 
EF-Tu .Considered the results, diagnostic test by ELISA can be 
interesting to use in routine, because of rapidity of its realization, low cost 
and possible development of high put screening which required only 
small amount of patient’s sera (less than 1µl). However, ELISA will be 
recommended to be use in parallel with IFA reference method and 
adsorbed western-blot which is more sensitive and allows an earlier 
diagnosis than IFA. The main drawback of adsorbed western blot is time-
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consuming, required large amount of both: patient’s serum samples and 
bacteria. Moreover, the specific choice of bacteria to be tested is based on 
patient’s anamnesis and the epidemiological data. Optimization of 
recombinant proteins based ELISA may be an interesting alternative for 
diagnosis of rickettsial diseases. 
 
Conclusion 
This study was designed for production of recombinant proteins useful 
for Rickettsiae detection in clinical samples. We have successfully cloned 
and expressed 43 rickettsial proteins. Finally, we selected several 
promising antigenic markers of R. typhi and R. conorii infection by using 
ELISA which can be alternative method for rickettsial diseases diagnosis. 
Despite interest of this test in clinical routine, the larger panel of sera 
should be tested before and not yet tested recombinant proteins remain to 
be screened.  
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Figure 1  
The reactivity of sera from patients infected by R. typhi, R. conorii, as 
well as sera from blood donors (control group) against the various 
recombinant proteins were tested by ELISA. The different recombinant 
proteins used as antigens are listed along the x axis (A. The recombinant 
proteins of R. prowazekii, strain MadridE; B. recombinant proteins of R. 
rickettsii strain Sheila Smith) The axis y shows the normalized results 
(unity of absorbance A405/cut-off measured for each antigen). The points 
of scatter which exhibit the value of report >1 are considered as positive. 
The cut264 off value was defined as mean ±1.5 SD of A405 value 
obtained with control group. 
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Table 1  
Orthologs of R.conorii in R.prowazekii and R.rickettsi-selection of 
protein targets for cloning and expression based on 
immunoproteomic studies 
 
 
 
Table 2 
 Base-line characteristics of the 48 subjects included in this study 
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Table 3 
 Test-operating parameters of 20 recombinant proteins included in 
the present study  
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Supplementary Material 
SM1 
Listing of all rickettsial ORFs selected for cloning and expression. The 
table is divided onto R. rickettsii and R. prowazekii targets. In grey is 
presented the first series of experiments targeting immunoreactive 
proteins.
 Protein name  locus_tag Strain Expression
&purificati
on 
ELISA peptide signal or THM 
1 
cell surface antigen  A1G_00130 
 
RR Sheila Smith -  MNKLTEQHLLKKSRFLKYSLLASIAVGAAIPFE 
2 50S ribosomal protein L1  A1G_01020 (rplA) RR Sheila Smith -   
3 leucyl aminopeptidase A1G_01050 RR Sheila Smith -   
4 
 molecular chaperone DnaK A1G_01335 (DnaK) RR Sheila Smith 
-   
5 hypothetical protein A1G_01695 A1G_01695 RR Sheila Smith -   
6 chaperonin GroEL A1G_05315 RR Sheila Smith -   
7 
elongation factor Tu A1G_05565 RR Sheila Smith - tested MAKAKFERTKPHVNIGTIGHVDHGKTSLTAAITIVLAKTGGAQA 
8 outer membrane protein B (cell surface antigen sca5) A1G_06030 RR Sheila Smith -  MAQKPNFLKKLISAGLVTASTATIVASFAGSAMGAAI 
9  F0F1 ATP synthase subunit epsilon  A1G_06755 (atpC) RR Sheila Smith + tested MNATILVKIITPLSIA 
10 Maf-like protein  A1G_06950 
 
RR Sheila Smith +   
11 hypothetical protein A1G_07045 A1G_07045 RR Sheila Smith +  MKKLLLIAAASTALLTSGLSFA 
12 hypothetical protein A1G_07050 A1G_07050 RR Sheila Smith -  MKKLLLIAATSATILSSSVSFA 
    3/12=25%   
13 outer membrane assembly protein (asmA)  A1G_02675 RR Sheila Smith -  THM : KYSLIIFISIILLLIVIPFFIPL 
14 asmA DOMAINE 1-705 aa A1G_02675 RR Sheila Smith +  THM : KYSLIIFISIILLLIVIPFFIPL 
15 hypothetical protein A1G_06970  (PLD) A1G_06970 PLD RR Sheila Smith + tested THM : NNKFIEISIAFILGIALGI 
16 
hypothetical protein A1G_02185   (VapB1) 
A1G_02185 
VapB1 RR Sheila Smith 
+ tested  
17 
hypothetical protein A1G_02180  (VapC1) 
AG1_02180 
VapC1 RR Sheila Smith 
+ tested THM1 : MGLIIDTAIIIALER 
THM2 : GQTYISPIVLTELLIGVDR 
THM3 : KCLAFIEYVKSLFTILPFGIEEV 
18 
hypothetical protein A1G_02181 (VapC2) 
AG1_02180 
VapC2 RR Sheila Smith 
+   
19 hypothetical protein A1G_07220  (VapC3) AG1_07220 vapC3 RR Sheila Smith -   
20 bifunctional N5-glutamine S-adenosyl-L-methionine-dependent 
methyltransferase/tRNA (m7G46) methyltransferase  A1G_07200 RR Sheila Smith 
+   
21 cell surface antigen-like protein Sca13  A1G_06915 Sca13 RR Sheila Smith + tested  
22 cell surface antigen-like protein Sca10  A1G_00295 Sca10 RR Sheila Smith + tested  
23 O-sialoglycoprotein endopeptidase  A1G_00390 RR Sheila Smith +   
24 cell surface antigen-like protein Sca8  A1G_01440 RR Sheila Smith +   
25 cell surface antigen-like protein Sca8  A1G_01445 RR Sheila Smith -   
26 scaffold protein  AG1_04120 RR Sheila Smith +   
27 O-antigen export system ATP-binding protein RfbE  A1G_00015 RR Sheila Smith +   
28 Mrp protein  A1G_00940 RR Sheila Smith +   
29 UDP-3-O- A1G_00045    RR Sheila Smith +   
30 UDP-N-acetylglucosamine acyltransferase  A1G_00035 RR Sheila Smith +   
31 dihydrofolate reductase  A1G_00215 RR Sheila Smith + tested  
32 folate synthesis bifunctional protein  A1G_00225 RR Sheila Smith +   
33 Sco2 protein precursor  A1G_00265 RR Sheila Smith +  THM : IIKIFIALAMITGIIFLCLLYSS 
34 soj protein  A1G_00540 RR Sheila Smith + tested  
35 stage 0 sporulation protein J  A1G_00545 RR Sheila Smith -   
36 
putative inner membrane protein translocase component YidC  A1G_00475 RR Sheila Smith 
-  THM1 : NIINLIAAIILSLSIIFGWQYFV 
THM2 : AIDFGWFYIITKPVFYAMNFFYG 
THM3 : NFGVSILIVTVIIKLLMFTLANK 
THM4 : AGCLPILVQIPVFFSIYKVLYVT 
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37 S-adenosyl-methyltransferase MraW  A1G_04755   RR Sheila Smith -   
38 penicillin-binding protein  A1G_04745 RR Sheila Smith -   
39 UDP-N-acetylglucosamine 1-carboxyvinyltransferase  A1G_04875 RR Sheila Smith -   
40 3-deoxy-D-manno-octulosonic-acid transferase  A1G_00700 RR Sheila Smith -  THM : YYALSFILLPVYFIIILIRLLIG 
41 antitoxin of toxin-antitoxin system  A1G_04925 RR Sheila Smith -  MAIFMTVITNRISNA 
42 peptidoglycan-associated lipoprotein precursor  A1G_06560 RR Sheila Smith -  MKTKITLAFLALCMLAGCN 
43 S-adenosylmethionine synthetase (adometK) A1G_06605 RR Sheila Smith -   
44 hypothetical protein A1G_05015  (RickA) A1G_05015 RR Sheila Smith + tested  
45  partie B-peptide de sca5 (A1G_06030) A1G_06030 RR Sheila Smith -   
 
 
 
 
23 
positive/45
=51% of  
expressed 
proteins 
10/23 tested 15/45 with PS or TM=33% of membrane proteins 
 R. prowazekii      
1 Cell surface antigen Sca1 (SPLIT GENE) RP016 RP Madrid E - tested MNKLTAQNLLKKSRFLKYSLLTSISVGAVMAIPVE 
2 Cell surface antigen Sca1 (SPLIT GENE) RP017 RP Madrid E -   
3  Cell surface antigen Sca1 (SPLIT GENE)190 KD ANTIGEN PRECURSOR 
(sca1) RP018 RP Madrid E 
-   
4 50S ribosomal protein L1 (rplA) RP137 RP Madrid E +   
5 Aminopeptidase A [EC:3.4.11.1](pepA) RP142 RP Madrid E + tested  
6 DnaK RP185 RP Madrid E -   
7 groEL; 60 kD chaperonin RP626 RP Madrid E + tested MAKAKFERTKPHVNIGTIGHVDHGKTSLTAAITIILAKTGGAKA 
8 Elongation factor EF-Tu (tuf) RP661 RP Madrid E +  MAKAKFERTKPHVNIGTIGHVDHGKTSLTAAITIILAKTGGAKA 
9  ompB, sca5; Outer membrane protein rOmpB RP704 RP Madrid E -  MAQKPNFLKKIISAGLVTASTATIVAGFSGVAMGAAM 
10 atpC; ATP synthase epsilon chain [EC:3.6.1.14] RP800 RP Madrid E -   
11 maf; Nucleotide-binding protein implicated in inhibition of septum formation RP815 RP Madrid E +   
12 Unknow/ADR1 RP827 RP Madrid E -  MKKLLLIAATSTALLTSGISFA 
13 
 Putative outer surface protein/ADR2 RP828 RP Madrid E + tested PS :MKKLLLIATASATILSSSVSFA THM : LLLIATASATILSSSVSFAECID 
    6/13=46%   
14 DNA repair protein RECN (recN)  RP182 RP Madrid E -   
15 patatin B1 precursor (pat1)  RP602 RP Madrid E -   
16 UDP-N-acetylmuramate--L-alanine ligase  RP247 murC RP Madrid E + tested  
17 ) 3-demethylubiquinone-9 3-methyltransferase  RP622 RP Madrid E + tested  
18 hypothetical protein RP631  RP631 RP Madrid E + tested  
19 adenylate kinase  RP638 RP Madrid E -  MIVIFLGPPG 
20 response regulator PleD  RP237 RP Madrid E -   
21 ) hypothetical protein RP673  RP673 RP Madrid E +   
22 UDP-3-O- lpxC RP254 RP Madrid E -   
23 hypothetical protein RP688  RP688 RP Madrid E -  THM :SYTQNLLSFKNIIGLMLIIFAGI 
24 hypothetical protein RP689  RP689 RP Madrid E +  SFKNIIGLMLIIFAGILFYAYIL 
25 hypothetical protein RP691  RP691 RP Madrid E -   
26 O-antigen export system ATP-binding protein RFBE (rfbE)  RP003 RP Madrid E -   
27 capsular polysaccharide biosynthesis protein CapD  RP333 RP Madrid E -   
28 SOJ protein (soj)  RP058 RP Madrid E -   
29 
stage 0 sporulation protein J (spo0J)  RP059 RP Madrid E 
+ tested  
30 
preprotein translocase subunit SecB  RP070 RP Madrid E 
-   
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43/93=46% iin total expressed proteins 
 
In bold and table in grey : first series of experiment, THM: transmembranary region; 
30 
preprotein translocase subunit SecB  RP070 RP Madrid E 
-   
31 
DOMAINE PFAM 447-768 omp1 RP160 RP Madrid E 
+ tested THM :KIISISKLTILLLTIFYYHISFA 
32 
minor teichoic acids biosynthesis protein ggab (ggab)  RP339 RP Madrid E 
+  MKQNIYSPLVSIIIPVYN 
33 
signal recognition particle protein  RP173 RP Madrid E 
+ tested  
34 hypothetical protein RP789  RP789 RP Madrid E +   
35 hypothetical protein RP527  RP527 RP Madrid E -   
36 
S-adenosyl-methyltransferase MraW  RP569 RP Madrid E 
+   
37 methionyl-tRNA synthetase  RP683 RP Madrid E -   
38 
preprotein translocase subunit SecA  RP0575 RP Madrid E 
-   
39 
DOMAINES Cterm 606-906 SecA RP0575 RP Madrid E 
+   
40 
) translation-associated GTPase  RP604 RP Madrid E 
-  MTLKLGIVGLPNVG 
41 thioredoxin reductase (trxB1)  RP445 RP Madrid E +  MKITTKVLIIGSGPAGLSAAIYTAR 
42 
peptidoglycan-associated lipoprotein precursor (pal)  RP771 RP Madrid E 
+  MKTKITLAFLALFMLAGCN 
43 HEAT shock protein (hsp22)  RP273 RP Madrid E -  MLKYIPAIFAIILSSNIA 
44 
outer membrane assembly protein (asmA)  RP347 RP Madrid E 
-  THM : KYSLIIFITIILLLIIIPFFIPL 
45 
DOMAINE asmA 1-711 aa RP347 RP Madrid E 
-   
46 
hypothetical protein RP819             (PLD) RP819 PLD RP Madrid E 
-  THM :FIAVSISFILGIALGIYVESTYY 
47 
S -adenosylmethionine synthetase metK  (adometK) RP777 RP Madrid E 
-   
48 
 ompB, sca5; Outer membrane protein rOmpB (sca 5 1353-1643, RP704, 
partie B-peptide) RP0688 RP Madrid E 
-   
 
   
20/48=42
% 
expressed 
proteins 
10/22 tested by 
ELISA 
17/48 with PS or THM=35% 
 
 
 
SM2 
On the left part of figure (A to D) are shown some examples of cases with 
R. typhi infections. 
On the right part of figure (E to H) are shown some examples of cases 
with R. conorii infections.  The graphs which display the results from IFA 
are shown on the right. On the axis X are shown the different rickettsial 
antigens screened with patient’s serum, on the axis Y, are shown the Ab 
titer IgG/IgM. 
The first WB corresponds to primary WB performed with not adsorbed 
serum of patients. The following WBs, if present, is performed with 
adsorbed by different rickettsial antigens (chosen according to the clinical 
context and results of primary WB) sera. 
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The Rickettsia genus is a group of obligate intracellular α- 
proteobacteria that includes human pathogens responsible for the typhus 
disease and spotted fevers, and which are associated with arthropods 
vectors (Raoult and Roux, 1997). Last ten years, the advent of whole 
genome sequencing has fundamentally improved research in rickettsial 
pathogenicity. The putative role of some proteins in critical steps of 
rickettsiae-host cell interactions was highlighted (Walker, 2007; Balraj et 
al., 2009). However, and while these post-genomic investigations 
contributed to gain a better knowledge about rickettsia pathogenicity, 
several points remain to be clarified.  
The aim of my thesis was to use mAbs as new specific tools to explore 
rickettsia pathogenicity. Indeed, and as reviewed in the Introduction 
section, antibodies can indeed be used not only for diagnostic, but also for 
experimental purpose. 
Our first objective was to further characterize rickettsial adhesins 
Adr1 and Adr2 from R. prowazekii. Because the failure to express 
recombinant Adr1 protein, we focused our investigations on Adr2. Using 
an overlay assay coupled with mass spectrometry, we first confirmed its 
role as a bacterial ligand recognized by host cell proteins. Recombinant R. 
prowazekii Adr2 was then expressed through fusion with Dsbc in E.coli, 
purified and concentrated, thus allowing production of specific mAbs, as 
shown by western blot assays. The capacity of mAbs to inhibit 
rickettsiae-induced cytotoxicity, firmly demonstrated the role of Adr2 as 
a virulence factor (Article 1). These findings led us to conceive some 
complementary investigations. Thus, and while we evidenced that 
inhibition of rickettsiae-induced cytotoxicity occurred in vitro, infected 
animal models could also be used to confirm these results and reinforce 
the crucial role played by Adr2. In this respect, anti-Adr2 mAbs could be 
intraperitoneally administered to mice prior the rickettsial challenge. 
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Non-challenged, anti-Adr2 treated and challenged, untreated mice will be 
used as controls. Body weight, physical behavior and dealth also be 
recorded both prior and post- infection (Chan et al., 2011). Another main 
concern to be addressed in the field of rickettsial entry, is to identify the 
eukaryotic proteins interacting with Adr2. Such investigations could be 
carried out by yeast two-hybrid approach. 
Exploitation of the host-cell actin cytoskeleton is crucial for several 
microbial pathogens to enter and to disseminate within cells, thus avoiding 
the host immune response. R. conorii has the capacity to use the actin-
based motility system for promoting cell-to-cell spreading (Teysseire et 
al., 1992). The RickA protein that contains a domain with homologies 
with WASP-family proteins was thought to function as a nucleation-
promoting factor that directly activates the Arp2/3 complex (Gouin et al., 
2004; Simser et al., 2005). From in vitro actin branching assay performed 
with recombinant RickA, the involvement of additional bacterial or 
eukaryotic factors in reorganizing Arp2/3 complex generated Y-branched 
networks into parallel arrays was also suggested (Jeng et al., 2004). 
Because genetic manipulations were unfeasible, the role of RickA in the 
motility of rickettsiae was not formerly demonstrated. Instead, some points 
remained  unclear. Thus, and while RickA was found to be expressed on 
the bacterial surface, both signal sequence and hydrophobic domain that 
are respectively required for secretion and membrane anchorage of this 
protein are lacking (Gouin et al., 2004). Moreover, experiments achieved 
on R. raoultii evidenced that the motile phenotype could be dependent on 
the host cells and unrelated to the level of RickA expression (Balraj et al., 
2008). The results obtained in our study (Article 2) confirm that RickA is 
expressed over the entire bacterial surface of R. conorii and do not exhibits 
a polarized distribution as other bacterial components known to be 
responsible for intracellular motility including IcsA, ActA or BimA 
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(Goldberg et al., 1993; Kocks et al., 1993; Stevens et al., 2005). Our data 
fit well with the recently published work of  Kleba et al. (2010). Indeed, 
these authors took advantage of recent development of mariner-based 
transposon systems for rickettsia transformation and demonstrated that 
Sca2 mutant does not produce actin comet tails, suggestive of its role in 
actin-based motility.  
The third part of my research focused on the serodiagnostic test 
improvement. In diagnostic approach, various methods were replaced by 
new method which is easier to handle and guaranteed better sensitivity 
and specificity. For this reason efficient diagnostic test based on 
recombinant proteins was started. Twenty recombinant proteins targets 
were screened with patient sera by ELISA. We believe that some of these 
markers could be helpful in discriminating the infection due to R. typhi 
and R. conorii from clinical samples (Article 3). While the number of 
studies involving engineering recombinant proteins is still low, they could 
offer an interesting alternative to improve the diagnosis of infection with 
these fastidious microorganisms.  
In conclusion, and while clearly experiments remain to be done, I 
believe that this work has to a better knowledge of the molecular 
mechanisms involved in rickettsia pathogenicity. 
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